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ABSTRACT
CHARACTERIZATION AND EFFECTS OF SYSTEMIC AND OVARIAN GnRH IN
BEEF CATTLE
JERICA J. J. RICH
2020
Previous studies evaluating single and multiple GnRH injections at time of CIDR
removal/prostaglandin injection using the 7-day CO-Synch + CIDR protocol have
reported decreased interval to estrus and increased expression of estrus, or increased
conception rates, respectively. Thus, the objective of experiment 1 (Chapter 3) was to
compare the effects of supplementing GnRH at prostaglandin injection on expression of
estrus and conception rates in beef cows and heifers synchronized with different
protocols. The objective was conducted in two parts, in study 1, Beef cows (n = 161) and
heifers (n = 1803) from 16 herds over three years were synchronized using the 7-day COSynch + CIDR fixed time AI (FTAI) protocol or the MGA-PG FTAI heifer protocol and
were randomly assigned to receive one of three treatments at prostaglandin injection [0
µg GnRH (0); 5 µg GnRH (5); or 5 µg at prostaglandin injection and 5 µg 12 h later
(5+5)]. In study 2, Beef cows (n = 656) and heifers (n = 4552) from 24 herds over three
years were synchronized using the 7-day CO-Synch + CIDR fixed time AI (FTAI)
protocol or the MGA-PG FTAI heifer protocol and were randomly assigned to receive
one of two treatments at prostaglandin injection [0 µg GnRH (0) or 5 µg GnRH (5)]. In
Study 1, cows treated with 5 µg of GnRH tended to have increased FTAI conception
rates compared to heifers.
Bovine follicles with greater follicular fluid concentrations of estradiol had
decreased expression of GnRH-I and GnRH-II in granulosa cells (GC). The objective of
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experiment 2 (Chapter 4) was to characterize relative abundance of GnRH-I, GnRH-II,
and GnRH-IR mRNA within GC of follicles at specific stages of development. Across
all follicles, GnRH-I and GnRH-II were not influenced by stage (P = 0.49) but were
influenced by size (P < 0.0001). Smalls (4.55 ± 0.39 and 3.91 ± 0.44, respectively) had
greater expression (P ≤ 0.01) compared to mediums (0.83 ± 0.39 and 1.41 ± 0.44,
respectively) and larges (0.52 ± 0.47 and 2.12 ± 0.54, respectively). There was also a
stage by size interaction for GnRH-I, GnRH-II, and GnRH-IR (P ≤ 0.03). POST and
POST-PG smalls had increased (P ≤ 0.03) expression of GnRH-II and GnRH-IR mRNA
compared to PRE smalls. POST smalls had (P = 0.02) increased expression of GnRH-I
mRNA compared to PRE smalls. PRE mediums had increased GnRH-I and GnRH-II
mRNA expression (P ≤ 0.03) compared to POST-PG mediums. When only the largest
follicle for each animal was evaluated, stage of development influenced expression of
GnRH-I (P = 0.03) but not GnRH-II (P = 0.91) or GnRH-IR (P = 0.16). For GnRH-I,
PRE tended (P = 0.09; 2.28 ± 0.55) to have increased expression compared to POST
(0.92 ± 0.55) and did have greater expression compared to POST-PG (P = 0.01; 0.11 ±
0.55), and POST-PG follicles had increased follicular fluid estradiol-17β concentrations
(P < 0.0001) compared to PRE and POST follicles.
There is limited information on the functional role of GnRH at the level of the
ovary or any factors involved in its regulation. However, a considerable amount of
information exists regarding hypothalamic control of GnRH. Some factors at the level of
the hypothalamus that have been reported to be in opposition with or regulate GnRH and
GnRH neurons are POMC and its derivatives (i.e. α-MSH), NPY, AMH, and GnRH
itself. The objective of experiment 3 (Chapter 5) was to identify and characterize the
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localization of GnRH and factors that are known to regulate GnRH production at the
level of the hypothalamus within the bovine ovary. Immunohistochemistry against αMSH, NPY, GnRH, and AMH was performed on bovine ovarian cryosections. Colocalization of immunofluorescence for GnRH and these factors was present in the
granulosa cell layer(s) of primary, secondary, and small antral follicles as well as in
vessels and arteries within the stroma. Furthermore, NPY immunofluorescence was
detected in nerve fibers of the ovarian stroma surrounding follicles.
In summary, expression of estrus increased pregnancy success (P < 0.0001), but
supplementation with 5 or 5+5 µg of GnRH at prostaglandin injection did not improve
estrus response or conception rates in beef cows and heifers regardless of protocol.
Granulosa cell GnRH-I and GnRH-II mRNA abundance was increased in small, early
follicular stage follicles, with decreased concentrations of estradiol. The colocalization
of GnRH, α-MSH, NPY, and AMH within the granulosa cell layer(s) of follicles, and
within the nerve fibers and arteries within the ovarian stroma are suggestive of a local
role in regulating follicular growth and ovaria steroidogenesis.
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CHAPTER 1
LITERATURE REVIEW
INTRODUCTION

Estradiol is responsible for modulating many mechanisms involved in successful
reproduction, it regulates estrus expression (Allrich, 1994), uterine pH (Perry and Perry,
2008), endometrial gene expression (Bauersachs et al., 2005) and subsequent uterine
receptivity, and sperm transport affecting embryo development and survival (Larimore et
al., 2015). Specifically, cattle that expressed estrus prior to fixed time AI (FTAI) had
increased preovulatory estradiol concentrations (Perry and Perry, 2008) and up to a 27%
increase in pregnancy success compared to animals that did not exhibit estrus
(Richardson et al., 2016). However, it is not understood why some growing follicles
have increased estradiol production compared to other follicles (Jinks et al., 2013; Perry
et al., 2014).
Gonadotropin releasing hormone (GnRH), at the level of the hypothalamus,
activates the two-cell two-gonadotropin pathway that stimulates ovarian estradiol
production (Fortune and Quirk, 1988), and GnRH administered systemically in small
doses (5 μg) has been reported to elicit an LH pulse similar to a physiological pulse
(McLeod et al., 1984; Ginther and Beg, 2012). In a study where multiple small doses (5
μg) of GnRH were administered following CIDR removal/prostaglandin injection,
concentrations of estradiol were increased (Larimore et al., 2016). These studies
demonstrate that estradiol production from ovarian follicles could be stimulated with
systemically administered GnRH. In addition to the classical pathway, GnRH receptor
mRNA has been characterized in bovine granulosa cells (Ramakrishnappa et al., 2003;
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Rich, 2017), and GnRH has been reported to have local stimulatory and inhibitory actions
on steroidogenesis within the ovary (Sharpe, 1982; Janssens et al., 2000). However, the
role of GnRH in bovine follicles as it pertains to estradiol production and/or the
regulation of estradiol production has not been well characterized.
Therefore, the objective of this research was to determine the systemic and local
effects of GnRH in beef cattle by (1) characterizing the relative abundance of GnRH-I,
GnRH-II, and GnRH-IR mRNA in bovine antral follicles at specific stages of follicular
development, (2) administering supplemental doses of GnRH following prostaglandin
injection using two different synchronization protocols to measure changes in expression
of estrus, or conception rates to AI, and (3) characterizing immunohistochemical
localization of GnRH and factors that are known to regulate GnRH production at the
level of the hypothalamus within the bovine ovary. The hypotheses were that
systemically administered GnRH would improve estrus expression, that GnRH-I and
GnRH-II within the follicle would down-regulate the ability of the follicle to produce
estradiol, and that factors that exist at the level of the hypothalamus to control GnRH
production and secretion would be present in bovine ovarian follicles.
To allow for deeper understanding of the studies that have been conducted herein,
a review of relevant literature providing a basis of fundamental information and research
pertaining to the objectives and hypotheses of this dissertation has been provided.
Starting with the bovine estrous cycle and folliculogenesis through endocrine glands of
the hypothalamo-pituitary-gonadal axis, and local (ovarian) and systemic (circulatory)
classification and regulation of GnRH and other associated reproductive hormones.

3
BOVINE ESTROUS CYCLE

The bovine estrous cycle is characterized by the events that occur between periods
of sexual receptivity (Fortune, 1994; Forde et al., 2011). Sexual receptivity is also
referred to as expression of estrus or standing heat, and the primary stimulus to display
estrus is increased concentrations of circulating estradiol (Vailes et al., 1992; Allrich,
1994). The average length of the estrous cycle is 21 days (17 to 24 days), and the
average length of standing heat is 14 hours (6 to 24 hours). The estrous cycle consists of
two to three follicular waves and each wave begins with the recruitment of a cohort of
small antral follicles from the pool of growing small antral follicles. One follicle is
selected from this cohort and continues to grow to attain dominance and ovulate, while
the remaining follicles become atretic. Ovulation occurs approximately 30 hours after
the onset of standing estrus (Chenault et al., 1975; Christenson et al., 1975; Lemon et al.,
1975), and ovulation is considered day 0 of the estrous cycle (Fortune, 1994; Forde et al.,
2011).
The estrous cycle can be divided into two phases, the follicular phase where the
predominant structure is the growing follicle and the luteal phase where the predominant
structure is the corpus luteum. During the luteal phase (days 1 to 17 of the estrous cycle),
the corpus luteum secretes progesterone. The most important role of the corpus luteum is
the production of progesterone (Smith et al., 1994). During the follicular phase (days 18
to 21 of the estrous cycle), growing ovarian follicles secrete estradiol (Senger, 2003).
Increased concentrations of estradiol produced from the dominant ovarian follicle, in the
absence of progesterone, act on the hypothalamo-pituitary-gonadal axis to regulate
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gonadotropin release and subsequently cause expression of estrus and sexual receptivity
(Vailes et al., 1992; Allrich, 1994).

FOLLICULAR DEVELOPMENT

The predominant structure of the follicular phase of the estrous cycle is the
ovarian follicle. The dynamics of follicular development include many processes:
activation, recruitment, selection, dominance, and ovulation or atresia (Fortune, 1994;
Bodensteiner et al., 1996a; Bodensteiner et al., 1996b; Howles, 1997). As follicles
progress through these developmental stages they transition from primordial (nongrowing) to primary, secondary, and tertiary antral follicles. There are typically two to
three waves of follicles per each estrous cycle (Rajakoski, 1960; Ireland and Roche,
1983; Roche and Boland, 1991; Fortune, 1994; Forde et al., 2011). Follicular growth
processes, and characteristic changes in type throughout the different developmental
stages will be discussed in the subsequent sections.

Follicle formation

Development of follicles in cattle begins during gestation (Henricson and
Rajakoski, 1959). Primordial germ cells migrate to the gonadal ridge at about day 35 and
colonize the undifferentiated gonad that develops along the dorsal body wall from a mass
of mesodermal cells (Anderson and Hirshfield, 1992). The primordial germ cells
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undergo many mitotic divisions resulting in rapid proliferation to germ cell numbers
close to 3 million by day 110 of gestation, they then enter into a state of quiescence
before they begin to undergo meiotic divisions, meiosis is not completed and oocytes are
arrested and become more susceptible to atresia and necrosis resulting in a precipitous
decline in germ cell numbers to hundreds of thousands around day 150 of gestation
(Erickson, 1966a; Erickson, 1966b; Anderson and Hirshfield, 1992; Burkhart et al., 2010;
Santos et al., 2013). At birth cattle have approximately 133,000 total primordial follicles,
whose numbers remain consistent until around four years of age when they begin to
progressively deplete due to initiation of growth and ovulation or atresia until there are
few to none remaining by twenty years of age (Erickson, 1966a). This finite pool of
primordial follicles serves as the ovarian reserve for which all developing follicles
originate (Erickson, 1966b). The establishment of the ovarian reserve and its gradual
depletion through activation of primordial follicles and subsequent recruitment and
growth are vital processes for female fertility.

Activation

For follicles to enter the growing pool and development to commence, quiescent
primordial follicles of the ovarian reserve must first be activated. In the last 20 years or
so significant efforts have led to a better understanding of the factors responsible for
activating primordial follicles. The possibility that extragonadal factors such as
gonadotropins were not needed for initiation of follicular growth was first suggested by
Eppig and O'Brien (1996) in studies using newborn mice ovaries in culture. Insights into
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factors regulating follicular activation were discovered following culture of cortical
sections of bovine fetal ovaries. When bovine fetal ovaries were collected and cultured,
there was an increase in the ratio of primordial to primary follicles; determined via
histological methods, with decreases in primordial follicle numbers of 95% and increases
in primary follicle numbers of 187% by culture day seven, indicative of the removal of an
inhibitor of follicular growth or increased activation (Wandji et al., 1996). This gave rise
to the concept of local ovarian inhibitors.
In a study where bovine cortical pieces were transplanted beneath the chorioallantoic membrane of gonadectomized chick embryos, anti-Müllerian hormone (AMH)
was reported to inhibit follicle activation (Gigli et al., 2005). Immunohistochemical
analysis of fetal ovaries showed staining for AMH in secondary and small antral follicles
(Yang et al., 2017). The AMH produced by secondary and later stage follicles is
responsible for inhibiting activation of quiescent primordial follicles (Fortune et al.,
2010; Yang et al., 2017). Factors that have been reported to stimulate activation of
primordial follicles are KIT ligand and insulin (Fortune et al., 2011). Fortune et al.
(2011) reported a dose dependent effect on follicle activation evidenced by fewer
primordial and an increased number of primary follicles in bovine cortical pieces cultured
with graded doses of KIT ligand. Once a primordial follicle enters the growing follicular
pool it can continue to grow, become selected and attain dominance, and eventually
ovulate. Follicular loss as a result of atresia can occur at any of these stages of
development.
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Recruitment

Recruitment is a process by which a cohort of follicles begin to develop in an
environment of gonadotropic stimulation progressing towards the ultimate result of
ovulation (Lucy et al., 1992). Each follicular wave is initiated by increased
concentrations of FSH, this transient rise in FSH is responsible for the recruitment of a
cohort of follicles that are around 3 mm in diameter (Fortune et al., 1991; Adams et al.,
1992; Evans et al., 1994; Hendriksen et al., 2003). Peak concentrations of FSH and FSH
receptor mRNA expression occur when the future dominant follicle is approximately four
mm in diameter, and thereafter FSH concentrations begin to decline (Ginther et al., 1996;
Bao et al., 1997a). The decline in circulating concentrations of FSH is driven by
increased concentrations of estradiol produced from the growing follicles of the recruited
cohort (Ginther et al., 2000). The dynamics of follicular growth and feedback of ovarian
steroid hormones allow for ovarian exposure to basal concentrations of FSH that result in
the production of a follicular wave about every seven days (Fortune et al., 1991).
Steroidogenic enzyme expression (P450 scc, P450 17α, 3βHSD, P450 arom) has been
characterized during follicular recruitment. Specifically, increased expression of P450
scc and P450 arom mRNA within granulosa cells was associated with follicular
recruitment in cattle (Bao et al., 1997a). The presence of these steroidogenic enzymes is
supportive of the fate of the recruited follicles to continue to grow, produce more
estradiol, progress towards selection and ultimately gain dominance and ovulate (Bao and
Garverick, 1998).
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Selection

Follicle selection is a process in which in most instances a single follicle from the
cohort of recruited follicles becomes dominant and continues to grow while the
remaining follicles become subordinate and undergo atresia (Fortune et al., 1991).
Follicle selection occurs about two to three days after recruitment and three to four days
prior to ovulation of the future dominant follicle (Pierson and Ginther, 1988; Ginther et
al., 1997). Any follicle of a follicular wave that reaches five mm has the potential to
become the dominant follicle, and will become subordinate only if selected against
during the deviation phase (Ginther, 2016). The pivotal event of follicle selection is
diameter deviation, and the intrafollicular factors involved in diameter deviation are the
IGF system, estradiol, and LH-R. The mean follicle diameter at deviation is greater than
or equal to eight mm (Kulick et al., 2001; Ginther, 2016). Specifically, concentrations of
free IGF-I and estradiol in follicular fluid as well as LH-R in the follicular wall increase
more dramatically in future dominant follicles than future subordinate follicles (Beg and
Ginther, 2006). In a study investigating the fates of the three largest follicles of a
follicular wave, increased estradiol concentrations were detected in the future dominant
follicle just before deviation and free IGF-I in the future dominant follicle remained
constant but was decreased in future subordinate follicles (Beg et al., 2002). In studies
with ovarian auto-transplants in sheep and then with serum-free granulosa cell culture
systems in both sheep and cattle, Campbell et al. (1995) determined that the IGF-I and
insulin system interact to affect ovarian cellular proliferation and estradiol production.
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The relationship of intrafollicular steroid hormones, growth factors, extraovarian
factors, and the hypothalamo-pituitary-gonadal feedback axis as they pertain to
folliculogenesis and specifically selection have been well studied and as a result three
models of follicle selection have been proposed. The first model is increased LH
receptor expression in granulosa cells and a shift from FSH to LH dependency (Xu et al.,
1995; Bao et al., 1997a; Ginther et al., 2001). The decline in circulating concentrations
of FSH is driven by increased concentrations of estradiol produced from the growing
follicles of the recruited cohort (Ginther et al., 2000). Additionally, the increased
concentrations of estradiol and inhibin may feedback on the HPG axis to suppress FSH as
well (Martin et al., 1988). The second model is increased concentrations of estradiol
preceding the shift in gonadotropin dependence from FSH to LH (Evans and Fortune,
1997). The increased production of estradiol of the future dominant follicle is supported
by evidence of increased expression of steroidogenic enzymes (3βHSD, P450 arom, P450
scc, and P450 17α) and StAR expression (Bao et al., 1997a, b; Bao et al., 1998; Bao and
Garverick, 1998). Specifically, increased expression of LH-R and 3βHSD mRNA in
granulosa cells is associated with selection of dominant follicles (Bao and Garverick,
1998). Lastly, the third model is increased availability of insulin-like growth factors to
stimulate follicular cell growth and differentiation (Giudice, 1992; Campbell et al., 1995;
Spicer and Echternkamp, 1995). Evidence to support this third model is based on the
future dominant follicle acquiring IGF-BP protease activity which leads to a decrease in
IGF-BP and an increase in free IGF, that synergizes with FSH to cause increased
estradiol production (Fortune et al., 2004). These changes in estradiol and the IGF
system could account for the greater FSH responsiveness of the future dominant follicle
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at the beginning of diameter deviation (Beg et al., 2002). The three models of follicle
selection revolve around the future dominant follicle’s ability to produce increased
concentrations of estradiol and have an increased growth rate in an FSH environment that
does not sustain the growth of other follicles (Mihm and Austin, 2002; Ginther, 2016).

Dominance

Dominance is the process by which the potentially ovulatory follicle escapes
atresia. Following successful selection, only selected dominant follicles express 3βHSD
mRNA within granulosa cells, allowing for maximal steroid production (Bao et al.,
1997b). The dominant follicle continues to grow at a faster rate while the subordinate
follicles eventually undergo atresia, and inhibits the emergence of a new follicular wave
until dominance is lost or ovulation occurs (Ginther et al., 1996). The single dominant
follicle within the cohort of antral follicles, more effectively binds gonadotropins, has
increased estradiol concentrations and continues to grow to preovulatory status (Ireland
and Roche, 1983; Quirk et al., 2004).
There are two hypotheses surrounding the explanation of how the dominant
follicle exerts dominance. Following attainment of dominant follicle status, the dominant
follicle becomes the primary inhibitor of FSH secretion via negative feedback
mechanisms at the level of the HPG axis; low level FSH concentrations and the inhibition
of transient rises in FSH prevent the emergence of a new cohort of growing follicles
(Fortune, 1994; Aerts and Bols, 2010). The second hypothesis states that dominant
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follicles secrete factors that inhibit subordinate follicles directly at the level of the ovary.
Dominant follicles produce factors (Activin A) that can help stimulate their own growth
but locally inhibit growth of small follicles (Mizunuma et al., 1999; Ginther et al., 2002).

Atresia

Growth and maturation of ovarian follicles involves continuous renewal of
granulosa cells which is regulated by apoptosis (Rosales-Torres et al., 2000). The
initiation of apoptosis in granulosa cells is one of the earlier signs of atresia, and is a
process in which unwanted cells can be selectively eliminated (Tilly and Hsueh, 1993b;
Yuan and Giudice, 1997). If key survival-promoting factors (estradiol, IGF) are depleted
apoptosis of granulosa cells commences (Matsuda et al., 2012). The granulosa cells layer
lines the basement membrane, and as most granulosa cells become apoptotic in
progressed atretic follicles the affects begin to spread. The basement membrane of atretic
follicles was fragmented, and atresia was associated with the penetration of theca cells
into the follicles (Bagavandoss et al., 1983). Oocyte degeneration is sustained until the
last stages of atresia (Driancourt, 1991). Additionally, follicular atresia was associated
with reduced expression of StAR mRNA in theca cells (Bao et al., 1998). Atresia of
bovine germ cells and follicles occurs during gestation and throughout life (Erickson,
1966a; Erickson, 1966b; Erickson, 1978; Santos et al., 2013). Specifically, it has been
hypothesized that germ cell loss during fetal development is a means by which surviving
oocytes gain additional follicular cells before follicular formation (Sawyer et al., 2002).
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In a study utilizing abattoir sourced ovine ovaries, antral follicles were
microscopically classified into four groups: ‘‘non-atretic’’(stage 1), initially atretic
(stage2), moderately atretic (stage 3a), and severely atretic (stage 3b) (Rosales-Torres et
al., 2000). In this same study, estradiol (E2) and progesterone (P4) were determined by
radioimmunoassay (RIA) in the follicular ﬂuid. The results of the study indicated that
there were differences in E2 concentration, and in the P4/E2 ratio in relation to the
microscopic classiﬁcation of atresia. The E2 concentration was dependent on the
interrelationship between follicular size and atresia group. Estradiol concentration in
follicular ﬂuid decreased from non-atretic to severely atretic follicles and was highly
correlated to stage of atresia (R2 = 0.73, P < 0.01). Additionally, the P4/E2 ratio was also
correlated with stage of atresia (R2 = 0.53, P < 0.05). Hernandez-Coronado et al. (2015)
further elucidated the previous classified estradiol and progesterone of the different
atretic groups and determined a criterion in classifying atretic versus healthy bovine
antral follicles, they did this by taking the previously reported concentrations of estradiol
and progesterone for the different stages of atresia and then determining the E2/P4 ratios.
Bovine antral follicles were classified as healthy when the E2/P4 ratio was greater than or
equal to one and atretic when the ratio was less than one (Rosales-Torres et al., 2000;
Hernandez-Coronado et al., 2015).

FOLLICLE TYPES

As follicles progress through different developmental stages their cellular makeup
changes drastically, and considerable investigation and histological analyses have been
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conducted to characterize follicle types. The following section is focused on describing
the types of follicles and their unique cellular components.

Cellular components of a follicle

Bovine follicles consist of an oocyte, a zona pellucida, a basement membrane, and
specialized follicular cells, the presence or absence of these various components changes
with different follicular developmental stages (Figure 1). The steroidogenic follicular
cells are granulosa cells and thecal cells. The size and amount of each component of a
follicle varies with different follicular stages of development. The oocyte of a follicle
contains genetic material and has the propensity to give rise to another life. The
basement membrane consists of collagen, laminin, and fibronectin and serves to separate
the avascular oocyte and granulosa cell compartment from the vascular thecal cell
compartments throughout follicular growth until the time of ovulation or atresia where
the membrane becomes fragmented and permeability of the avascular compartment
increases (Bagavandoss et al., 1983).
Extensive research efforts studying the ontogeny of ovarian follicular cells in
various species lead to three hypothesized origins of granulosa cells. The three origins
and species in which they were discovered are: (1) in ovine fetal ovary studies
approximately 95% or greater of pregranulosa cells migrated from the superficial
epithelium of the developing ovary, this was evidenced by the persistence of
pregranulosa cells associated with dying germ cells and their subsequent re-association
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with the surviving germ cells (Sawyer et al., 2001; Juengel et al., 2002; Sawyer et al.,
2002) (2) in rat pup studies pregranulosa cells migrated from centrally located somatic
cells in the medulla of the ovary (Hirshfield, 1992; Hirshfield and DeSanti, 1995), and (3)
in many species pregranulosa cells migrate from mesonephric derived rete cell tubules
(Hirshfield, 1991a; Byskov, 1994; McNatty et al., 2000). More recently, it has been
proposed that in contrast to the previous theory of surface epithelial cells penetrating the
ovary to form granulosa cells, that rather the ovarian surface epithelium and granulosa
cells have a common ancestor, the gonadal ridge epithelial-like cell (Hummitzsch et al.,
2013).
The origin of theca cells is less clear, and there are two hypotheses of their origin,
the first being that theca cells share a common ancestor with fibroblasts and the stromal
connective tissue components of the ovary and the second being that theca cells share a
common ancestor with granulosa cells (Hirshfield, 1991a). Furthermore, there are two
classes of thecal cells, the steroidogenic parenchymal theca interna cells and connective
tissue theca externa cells (Hirshfield, 1991a, b).
The zona pellucida is an acellular matrix directly surrounding the plasma
membrane of mammalian oocytes that consists of three glycoproteins and is
approximately 7 µm thick (Green, 1997). The three glycoproteins are ZP1, ZP2, and ZP3
(Wassarman, 1988; Wassarman and Mortillo, 1991). The zona pellucida and its
specialized proteins play a very important role in successful fertilization (Bleil and
Wassarman, 1980; Wassarman, 1988; Wassarman and Mortillo, 1991).
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Figure 1. Schematic depiction of an antral follicle. The light orange circle with the black
condensed structure at the center represents the oocyte, the thick orange band
surrounding the oocyte is the zona pellucida, the blue circles represent the granulosa
cells, the open space among the granulosa cells represents the fluid filled antrum, and the
dark circle encasing the granulosa cells and oocyte is the basement membrane, the light
green ovals are the theca interna cells, and the darker green ovals are the theca externa
cells, the red lines denote the vasculature network that is intimately interlaced within the
theca cell layers.
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Primordial Follicles

The formation of primordial follicles (aka Type 1 follicles) begins during
gestation, around days 75-130 (Henricson and Rajakoski, 1959). Primordial follicles
formation begins around day 75 when oogonia enter meiosis and this meiosis continues
until around day 150 (Erickson, 1966a; Adams et al., 2008). Then, around day 90 to 170
the ovigerous cords become disrupted, and the surviving oocytes are surrounded by a
single layer of flattened pregranulosa cells and become enclosed in a basement membrane
(Erickson, 1966a; Van Voorhis, 1999). The newly formed primordial follicles are
located in the ovarian cortex directly beneath the surface epithelium surrounding the
entire ovary (van Wezel and Rodgers, 1996). Cattle are born with approximately 133,000
primordial follicles, and the pool of quiescent primordial follicles remains fairly constant
in number from their formation to around four years of age, after this time numbers begin
to decrease as a result of atresia and ovulation until there are few to none remaining by
around 20 years of age (Erickson, 1966b).
Primordial follicles of the adult bovine ovary are typically an oblong shape (45
µm x 30 µm x 26 µm), contain a single small oocyte that is encased in a complete
basement membrane, and are surrounded by a single layer of flattened granulosa cells and
have at least one cuboidal granulosa cell, which amounts to a total of about six granulosa
cells (Anderson and Hirshfield, 1992; van Wezel and Rodgers, 1996; Braw-Tal and
Yossefi, 1997). The oblong shape is attributable to clustering of granulosa cells at two
opposite poles on the long axis of the follicle (van Wezel and Rodgers, 1996). The first
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sign of growth of the primordial follicle into a more advanced follicular stage is the
growth of the surrounding granulosa cells, as they transition from flattened to cuboidal
(Anderson and Hirshfield, 1992; van Wezel and Rodgers, 1996). Primordial follicles can
be grouped into two classes; resting or activated primordial follicles, with the difference
being the presence of some cuboidal granulosa cells in the activated primordial follicles
versus solely squamous/flattened granulosa cells surrounding the resting primordial
follicles (Fair et al., 1997). Initiation of follicle growth and progression through the
different stages/types of follicles involves three key events: the change in shape of
granulosa cells (flattened/squamous to cuboidal), proliferation of the granulosa cells
resulting in increased layers (1 to > 6), and lastly enlargement of the oocyte, that
commences when there are about 40 granulosa cells (30 µm to 93 µm) (Hirshfield,
1991a; Braw-Tal and Yossefi, 1997; Santos et al., 2013).

Primary Follicles

The transformation of the flattened pregranulosa cells of the primordial follicles
into a single layer of cuboidal granulosa cells marks the transition from primordial to
primary follicle (Braw-Tal and Yossefi, 1997; Adams et al., 2008). Primary or type two
follicles typically have one to one and a half layers of cuboidal granulosa cells, are 40-80
µm in diameter, and do not have theca cells (Braw-Tal and Yossefi, 1997).
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Secondary Follicles

Proliferation of granulosa cells resulting in two to six layers surrounding the
oocyte is characteristic of secondary follicles (Lussier et al., 1987; Adams et al., 2008).
Secondary follicles can be subdivided into small preantral (type 3; two or three layers of
GC and are 81 to 130 µm in diameter) and large preantral (type 4; four or more layers of
GC and are 131 to 250 µm in diameter) (Braw-Tal and Yossefi, 1997). The primary
difference between these follicle types is the presence of a thecal cell layer. Type 3
follicles have two to three layers of cuboidal granulosa cells, are 80 to 130 µm in
diameter and do not contain a thecal layer (Braw-Tal and Yossefi, 1997). In cattle, the
zona pellucida was first detected in early preantral follicles (81 to 130 µm) but did not
completely surround the oocyte until the large preantral stage (131 to 250 µm) (Braw-Tal
and Yossefi, 1997).

Tertiary Follicles

Formation of a central fluid-filled cavity (antrum) is one of the last developmental
stages of folliculogenesis and is the special feature that separates preantral from antral
follicles (Anderson and Hirshfield, 1992; Adams et al., 2008). Antral follicles vary by
size of the antrum and are often characterized as small (less than 5 mm), medium (5 to 10
mm), or large (greater than 10 mm) (Matton et al., 1981). The follicular fluid that fills
the antrum is derived from secretions of the surrounding granulosa cells as a result of
fluid movement from the extra-follicular space (Rodgers and Irving-Rodgers, 2010).
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Bovine antral follicles are about 250 to 500 µm in diameter (Marion et al., 1968; BrawTal and Yossefi, 1997). Tertiary/antral follicles contain an oocyte surrounded by a zona
pellucida, many layers (> 6) of granulosa cells, a fluid-filled antrum and specialized
granulosa cells (cumulus cells) that surround the oocyte suspended within the follicular
fluid, all encased by a basement membrane (Adams et al., 2008). The basement
membrane provides a barrier from vascular circulation and serves to maintain a follicular
fluid environment rich in steroids, proteins, and growth factors conducive to oocyte
maturation and growth (Smith et al., 1994; Roche, 1996; Howles, 1997). Outside of the
basement membrane lies an inner layer of theca cells laced heavily with vascular
channels, this is the steroidogenic layer of theca cells that play a key role in the
production of the steroid hormone estradiol. The outermost layer of thecal cells
responsible for structural support of the follicle are referred to as theca externa cells and
most resemble smooth muscle cells (Anderson and Hirshfield, 1992).

HYPOTHALAMO-PITUITARY-GONADAL AXIS

The hypothalamo-pituitary-gonadal axis (HPG axis; Figure 2) is the highway of
communication between the brain and the reproductive tract that supports the transport of
releasing factors, protein hormones, and steroid hormones that play pivotal roles in
reproduction. The HPG axis is a system that encompasses the interrelationship of three
endocrine glands that regulate one another. The endocrine glands of the HPG axis are the
hypothalamus, the anterior pituitary also referred to as the adenohypophysis and pars
distalis, and the gonad, for the purposes of this dissertation the focus is: the ovary. The
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HPG axis has many levels of control resulting from feedback mechanisms, which will be
discussed in the subsequent sections. The proper functioning of this axis is fundamental
to successful reproduction and its various constitutive parts have been the focus of many
research endeavors. For the purposes of this dissertation, the HPG axis is being discussed
to highlight the systemic pathway of GnRH and its downstream effects.
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Figure 2. Hypothalamo-pituitary-gonadal axis, ovary-centric. Depicting the feedback
loop mechanisms of control.
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Hypothalamus

The hypothalamus is a very important neural endocrine structure located at the
basal portion of the diencephalon directly below the thalamus (Swaab et al., 1993). It
receives information from the central nervous system by synaptic connections with other
neural components and in response to these inputs secretes neurohormones that regulate
anterior pituitary function (McCann et al., 1968). The hypothalamus consists of bundles
of nerve cell bodies referred to as hypothalamic nuclei. Groups of hypothalamic nuclei
that regulate reproduction are called the tonic and surge centers and are responsible for
secreting gonadotropin releasing hormone (GnRH) (Senger, 2003). The hypothalamic
nuclei responsible for tonic GnRH release are: ventromedial nucleus (VMN), arcuate
nucleus (ARC), and the median eminence (ME) while the nuclei responsible for surge
GnRH release are: preoptic nucleus (POA), anterior hypothalamic area (AHA), and the
suprachiasmatic nucleus (SCN).
The secretory target of GnRH neurons is a specialized vascular structure known
as the primary portal plexus, that serves as a vascular connection between the
neurosecretory cells of the hypothalamus and the anterior pituitary gland, of the
hypothalamo-hypophyseal portal system in the median eminence (Plant, 2015).
Gonadotropin releasing hormone has a very short half-life (minutes) (Schally et al., 1972;
Nett et al., 1973; Redding et al., 1973; Jonas et al., 1975) and it is because of this that it
must be transported through these specialized portal vessels to arrive at its target organ in
adequate concentrations. Gonadotropin releasing hormone is released from the
mediobasal hypothalamus into the hypothalamo-hypophyseal portal vessels ultimately
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resulting in the binding to its receptor and the synthesis and secretion of luteinizing
hormone (LH) and follicle stimulating hormone (FSH) from gonadotrope cells of the
anterior pituitary (Schally et al., 1971; Schally et al., 1972; Walters and Schallenberger,
1984; Tandon and Rajesh Chintala, 2001; Kadokawa et al., 2014).
Gonadotropin releasing hormone secretion is regulated by combined feedback
actions of pituitary hormones and gonadal steroid hormones (McCann et al., 1968).
Changes in activity of hypothalamic neurons have been correlated with altered estrogen
levels, specifically the spontaneous activity in the AHA and POA of rats in high estrogen
states was reduced compared to ovariectomized rats, furthermore, the replacement of
estrogen via estradiol benzoate administration depressed activity to what was observed in
the persistently estrous rats (Lincoln, 1967; Lincoln and Cross, 1967). Ovariectomy and
implants of estrogen into the median eminence decreased the stored content of GnRH and
decreased secretion of gonadotropins in female rats (Chowers and McCann, 1965;
Piacsek and Meites, 1966). Implants of estrogen into the AP altered gonadotropin
secretion and caused an increase in the stored content of GnRH in female rat hypothalami
(Ramirez et al., 1964; Chowers and McCann, 1965). These reports provide evidence of
the hypothalamus being the principal site of gonadal steroid negative feedback
(Bogdanove, 1963; Ramirez et al., 1964).
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Anterior Pituitary

The anterior pituitary is a small vascular gland that is connected to the
hypothalamus by a small pituitary stalk. It contains various cell types that bind specific
releasing hormones to control physiological processes (McCann et al., 1968). The cell
types within the anterior pituitary important for controlling the gonad are referred to as
gonadotrope cells. Gonadotrope cells produce and secrete gonadotrophins (LH and FSH)
in response to GnRH. For the anterior pituitary to be acted upon by GnRH secreted from
neurons in the hypothalamus, the minute quantities of GnRH must be delivered without
being diluted by general circulation. The system responsible for facilitating this is
referred to as the hypothalamo-hypophyseal portal system (Plant, 2015). The
hypothalamo-hypophyseal portal system is a capillary network that is separate from
general circulation and allows for secretion and transport of GnRH from GnRH neurons
to the vascular anterior pituitary without dilution (McCann et al., 1968). Neurons secrete
GnRH from axon terminals into the primary portal plexus at the level of the median
eminence, the decapeptide then travels to the secondary portal plexus within the anterior
pituitary via portal vessels (Harris, 1955). Once GnRH makes its way into the secondary
portal plexus it is delivered to specific receptors on gonadotrope cells.
The synthesis and secretion of gonadotropins is controlled by secretions of GnRH
from the hypothalamus (McCann, 1962; McCann and Taleisnik, 1962; Ramirez and
McCann, 1963; Igarashi and McCann, 1964; McCann and Ramirez, 1964; Schally et al.,
1971) and from feedback mechanisms of gonadal steroids. Many studies verifying this
negative feedback control reported enhanced rates of synthesis and release of LH as
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demonstrated by increased plasma and pituitary levels of LH in male and female rats
when gonadal steroids were removed, and in these studies it was determined that LH is
far more responsive to the inhibitory actions of physiological doses of estradiol than FSH
(McCann and Ramirez, 1964; Parlow, 1964). Further, in a study using castrated male
mice there was an observed five-fold increase in pituitary LH and this post castration rise
was inhibited by steroid hormones estrone, testosterone, androstenedione, and
dehydroepiandrosterone (Ryan and Philpott, 1967). Similarly, even though the effects
were more delayed in comparison to LH, following ovariectomy there were increased
plasma (Igarashi and McCann, 1964; Parlow, 1964) and pituitary (Steinberger and
Duckett, 1966) levels of FSH and again following ovariectomy the increase in FSH was
diminished by administration of gonadal steroids (Parlow, 1964; McDonald and Clegg,
1966; Ryan and Philpott, 1967). Daily small dose injections of estradiol-17β into intact
rats resulted in decreased pituitary LH and increased plasma LH measurements after
seven days, indicating that when administered in small doses estradiol can be stimulatory
to LH release (Callantine et al., 1966). Evidence also exists that indicates LH feedbacks
negatively to regulate its own secretion, and this mechanism is likely in place to suppress
LH secretion at the end of the ovulatory surge (McCann et al., 1968).

Ovary

Systemic injections of estrogen can inhibit both release and synthesis of GnRH,
and estrogen can act directly on the pituitary to stimulate LH release (Piacsek and Meites,
1966). Ovaries are paired endocrine glands that are responsible for producing oocytes
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and steroid hormones. The dominant structure present during the follicular phase is the
follicle that produces estradiol-17β, and the dominant structure present during the luteal
phase is the corpus luteum that produces progesterone. Ovarian follicles have specialized
cells (granulosa and theca cells) that are involved in steroid hormone production. Theca
cells have LH receptors and granulosa cells have FSH receptors and some LH receptors
(Anderson and Hirshfield, 1992). These specialized cells contain receptors for the
gonadotropins released from the anterior pituitary, binding of gonadotropins to these
receptors is a critical first step in the mechanism of estradiol and other steroid hormone
production termed the two-cell two-gonadotropin model (Fortune and Quirk, 1988).
The predominant steroid hormone secreted from the ovary that is active in
feedback mechanisms of the HPG axis is estradiol-17β (Anderson and Hirshfield, 1992).
Estradiol secretion from ovaries feeds back to alter LH secretion from the anterior
pituitary gland (McCann et al., 1968). Increased production of estradiol from dominant
follicles feeds back positively to the gonadotrope cells during the follicular phase to
increase their responsiveness to GnRH, this allows for frequent LH pulses to occur for a
period of two to three days that causes increased estradiol production and prolonged
growing and maintenance of the dominant follicle (Piacsek and Meites, 1966; Fortune et
al., 2001).
Estradiol also feeds back to impact hypothalamic GnRH release, specifically
increased plasma estradiol concentrations increase GnRH pulse frequency through a
positive feedback mechanism (Aerts and Bols, 2010). Estradiol in bovine follicles has a
positive feedback loop to the hypothalamus to stimulate GnRH which induces LH release
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from the anterior pituitary (Baratta et al., 1994) by increasing the number of GnRH
receptors at the level of the anterior pituitary (Gregg et al., 1991).
Estradiol can augment LH release through GnRH, this augmentation is due to the
increase in pituitary responsiveness to GnRH (Reeves et al., 1971). In rats, pituitary
GnRH receptor concentrations were highest during proestrus when circulating
concentrations of estradiol were greatest, as well as following ovariectomy, these
findings were indicative of an ovarian agent causing partial negative effects on pituitary
GnRH receptors (Becker et al., 1979).
Another steroid hormone secreted by the ovary, progesterone, feeds back to the
hypothalamus and controls LH secretion and subsequently the expression of estrus
(Adams et al., 1992; Baratta et al., 1994; Janovick and Conn, 1996; Nett et al., 2002).
Progesterone has this negative effect on expression of estrus by negatively feeding back
to the hypothalamus to decrease GnRH and LH pulse frequency (Aerts and Bols, 2010).

TWO CELL-TWO GONADOTROPIN MODEL OF STEROIDOGENESIS

The two-cell two-gonadotropin model refers to the production of estradiol-17β via
coordinated actions of two key gonadotropins and two ovarian follicular cell types
(Falck, 1959; Erickson, 1978; Fortune and Quirk, 1988). The two follicular cells of the
pathway are the granulosa cells and the theca interna cells. The two gonadotropins are
LH and FSH. Specifically, theca interna cells contain LH receptors and granulosa cells
contain FSH and LH receptors (Bao and Garverick, 1998). The ovarian biosynthesis of
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estradiol is a pathway containing many intermediate steroidogenic products and their
respective enzymes, the process begins with sequestering of the 27-carbon molecule
cholesterol, the common steroid precursor (Hadley, 1992). Specifically the enzyme
steroidogenic acute regulatory protein (StAR), which is localized to the theca interna of
healthy follicles is responsible for the transfer of cholesterol from the outer mitochondrial
membrane to the inner membrane and is thus, the rate limiting step of steroidogenesis
(Stocco, 2001).
The capillary network present in the thecal interna cell layer is responsible for
supplying cholesterol for steroid hormone production. Cholesterol is delivered to the
theca interna where it is converted into pregnenolone by the enzyme cytochrome P450
side chain cleavage (P450scc), which cleaves the terminal six carbon side chain of
cholesterol. Both theca and granulosa cells contain cytochrome P450 side chain cleavage
enzyme (P450scc) responsible for the conversion of cholesterol to pregnenolone.
pregnenolone is then released from the mitochondria and from here it can participate in
several pathways, the most important being the delta 4 or delta 5 pathways. In the delta 4
pathway pregnenolone is converted to progesterone by the enzyme 3β-hydroxysteroid
dehydrogenase (3βHSD), then to 17-α-hydroxy-progesterone and androstenedione in two
steps via the enzyme 17-α-hydroxylase cytochrome P450 (P45017α). In the delta 5
pathway pregnenolone is converted to 17-α-hydroxy-pregnenolone and
dehydroepiandrosterone (DHEA) by the enzyme P45017α in two separate steps.
Dehydroepiandrosterone is then converted to androstenedione via the enzyme 3βHSD,
and this step is where the delta 4 and delta 5 pathways converge (Bao et al., 1997a). The
delta 5 pathway is preferred among bovine follicles that are stimulated by LH to convert
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DHEA to androstenedione by 3βHSD, but are unable to aromatize androgens to estrogens
(Ireland and Roche, 1983; Bao et al., 1997b).
Androstenedione is converted to testosterone by 3βHSD (Bao et al., 1997a).
Testosterone within the theca cells can then cross the basement membrane and enter the
granulosa cells. Granulosa cells bind FSH and convert testosterone into estradiol by
working in concert with the enzyme cytochrome P450 aromatase (P450arom) (Liu and
Hsueh, 1986; Fortune and Quirk, 1988; Bodensteiner et al., 1996b; Bao and Garverick,
1998). Increased expression of mRNA for StAR, steroidogenic enzymes, and
gonadotropin receptors resulted in maximal steroid hormone concentrations (Bao and
Garverick, 1998). Estradiol enters the circulation and plays a role in feedback regulation
of gonadotropins, as was discussed in the hypothalamo-pituitary-gonadal axis section and
is a key regulator in the expression of estrus, the ovulatory cascade, and the preparation
of the uterine environment for maintenance of pregnancy.

ESTRADIOL

As previously discussed increased circulating estradiol is the primary stimulus for
females to exhibit behavioral estrus (Allrich, 1994), and estradiol regulates uterine pH
(Perry and Perry, 2008), endometrial gene expression (Bauersachs et al., 2005), and
sperm transport (Larimore et al., 2015) that increase pregnancy establishment and
maintenance. Further in a meta-analysis of over 10,000 cows submitted to different
fixed-time artificial insemination, cows that exhibited estrus prior to the time of breeding
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had a 27% increase in pregnancy success compared to cows that did not exhibit estrus
(Richardson et al., 2016). Estradiol in bovine follicles has a positive feedback to the
hypothalamus to stimulate GnRH which induces LH release from the anterior pituitary
(Baratta et al., 1994) by increasing the number of GnRH receptors at the level of the
anterior pituitary (Gregg et al., 1991).
Furthermore, there was a positive relationship between follicle size and peak
estradiol concentration among cows that exhibited estrus (Perry et al., 2014). Previous
research has also reported a relationship with follicles size, circulating concentrations of
estradiol, and pregnancy success to AI among beef cattle (Perry et al., 2005). When
employing synchronization protocols for the use of artificial insemination, cattle are
sometimes forced to ovulate smaller follicles, with the administration of GnRH, in these
instances, animals experience decreased pregnancy success due to decreased estradiol
production of that smaller follicle (Perry et al., 2005).
Culturing of human granulosa-luteal cells with estradiol resulted in a decrease in
GnRH and GnRH-IR mRNA (Nathwani et al., 2000; Kang et al., 2001a). Specifically, at
concentrations as low as 1 nM of estradiol, GnRH mRNA abundance was reduced by
45% compared to the control, and at an estradiol concentration of 100 nM a 70%
decrease in GnRH mRNA was observed relative to the control. Similar results were
observed for GnRH-IR mRNA with a 40% and 65% decrease in GnRH-IR mRNA for the
1 nM and 100 nM concentration of estradiol, respectively (Nathwani et al., 2000).
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GONADOTROPIN RELEASING HORMONE

Gonadotropin releasing hormone is a neuronal secreting decapeptide that is a
crucial player in the homeostasis of the HPY axis and reproductive processes. Since its
discovery, 23 different forms of GnRH have been identified, among those, three distinct
isoforms have been characterized (GnRH-I, GnRH-II, and GnRH-III), the amine and
carboxyl terminal sequences, important for receptor binding and activation are highly
conserved among the different forms. The most common structural variations among the
different forms of GnRH occur in the amino acids between 5 and 8 in the sequence,
specifically the position 8 amino acid is the most variable (Millar, 2005). In mammals,
there are two forms: GnRH-I and GnRH-II.

GnRH-I

Hypothalamic GnRH, also known as type one mammalian GnRH or GnRH-I was
originally isolated and sequenced from millions of porcine hypothalami in the seventies
by the work of three scientists, Schally, Guilleman, and Yalow who later became Nobel
Laureates for their discovery in 1977 (Matsuo et al., 1971). Gonadotropin releasing
hormone-I is thought to work predominantly through the classical hypothalamo-pituitarygonadal axis where it stimulates gonadotropin secretion from the anterior pituitary.
Gonadotropin releasing hormone is the “master molecule” of the HPG axis and is largely
responsible for the initiation of the hormonal cascade. Mammalian GnRH is a
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decapeptide [pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2] with conserved amino
acid positions 1, 2, 3, 4, 9, 10 (Millar, 2005).
Gonadotropin releasing hormone neurons are located in the POA, ARC, and ME
of the hypothalamus (Clarke et al., 1987; Jansen et al., 1997). Gonadotropin releasing
hormone-I is released in a pulsatile manner and travels to target sites on gonadotropes in
the anterior pituitary. The synthesis and secretion of gonadotropins is controlled by
secretions of GnRH from the hypothalamus (McCann, 1962; McCann and Taleisnik,
1962; Ramirez and McCann, 1963; Igarashi and McCann, 1964; McCann and Ramirez,
1964; Schally et al., 1971). These gonadotropins then stimulate steroid hormone
synthesis and gametogenesis at the level of the gonad (Senger, 2003).

GnRH-II

A midbrain GnRH (GnRH-II) was isolated and sequenced from chicken
hypothalami, and was 30% as potent as mammalian GnRH (GnRH-I) in its ability to
cause the release of gonadotropins in a bioassay of rat gonadotrope cells (Miyamoto et
al., 1984). This form of GnRH is structurally conserved from bony fish to humans
meaning it is most likely the earliest evolved form of GnRH (Pawson et al., 2003), and is
different from GnRH-I by three amino acid residues in positions 5, 7, and 8 [pGlu-HisTrp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2] (White et al., 1998; Millar, 2003; Millar, 2005).
Gonadotropin releasing hormone-II occurs in the brain, pituitary gland, and reproductive
tissues, and expression of GnRH-II is highest outside of the brain (White et al., 1998).
The actions of GnRH-II have been reported predominantly in extra-pituitary sites,
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however at the level of the brain it appears to be a neuromodulator stimulating sexual
behavior (Millar, 2005; Barnett et al., 2006). Gonadotropin releasing hormone-II is
widely distributed in the central and peripheral nervous systems (Millar, 2003).
Interestingly, there are reports of GnRH-II inactivation in some mammalian
species (Reviewed by Desaulniers et al., 2017). The GnRH-II gene is silenced in the
mouse, leaving only the gene encoding GnRH-I (Pawson et al., 2003). Furthermore, in
cattle, a study revealed that the GnRH-II peptide is functionally inactive (Morgan et al.,
2006).

GnRH receptors

The amino acid sequence of GnRH-R was first deduced from mouse gonadotrope
cells (Tsutsumi et al., 1992), since then the cloning of pituitary GnRH-R has been
accomplished in the rat (Eidne et al., 1992), human (Chi et al., 1993), sheep (Brooks et
al., 1993; Illing et al., 1993), cow (Kakar et al., 1993), and pig (Weesner and Matteri,
1994). The receptors among these species share greater than 80% amino acid residues.
The GnRH-R is a member of the seven transmembrane domain receptor family that bind
to G-proteins and functions in the inositol phosphate signaling pathway. A unique
feature of the receptor for GnRH-I (GnRH-IR) is that it does not contain a carboxyterminal cytoplasmic tail, which is thought to be involved in internalization and
desensitization (Millar, 2005).
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The presence of two forms of GnRH in mammals is suggestive of the presence of
separate cognate receptors (Troskie et al., 1998). The GnRH-II receptor (GnRH-IIR) was
cloned and sequenced from the marmoset monkey and was present in areas of the brain
associated with sexual behavior (Millar, 2003). Gonadotropin releasing hormone-I
receptor is structurally and functionally different from the GnRH-II receptor.
Specifically, the GnRH-IIR contains a carboxy-terminal cytoplasmic tail and is 40%
homologous to GnRH-IR (Millar, 2003; Millar, 2005; Ramakrishnappa et al., 2005;
Desaulniers et al., 2017). Receptors for both GnRH-I and II are localized in the
gonadotrope cells of the anterior pituitary and because GnRH-IIR, in contrast to the
GnRH-IR, contains a carboxy-terminal cytoplasmic tail it is rapidly internalized
(McArdle et al., 2002a; McArdle et al., 2002b). In contract to GnRH-IR, the GnRH-IIR
is rapidly internalized, has a different signaling pathway, and preferentially stimulates
FSH secretion (Millar, 2003).
The presence of GnRH-II receptor within the brain is thought to mediate sexual
behavior, and its presence within reproductive tissues is suggestive of a local
paracrine/autocrine role of GnRH-II. Factors exist that are known to alter the mRNA
abundance of GnRH receptors and subsequently the number of GnRH receptors within
the anterior pituitary. These factors include gonadal steroids, estradiol, progesterone,
inhibin, activin, and GnRH itself in rats, sheep, and cattle (Gregg et al., 1991; Braden and
Conn, 1992; Turzillo and Nett, 1999). In humans, GnRH was reported to up-regulate
GnRH receptor gene expression (Peng et al., 1994).
Additionally, the presence of GnRH-IR in reproductive tissues is suggestive of
specific role in these tissue systems (Ramakrishnappa et al., 2005). The earliest reports
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of evidence of GnRH-IR systems in reproductive tissues were in radioligand binding
assays in rodent species (Clayton et al., 1979; Harwood et al., 1980; Jones et al., 1980;
Reeves et al., 1980; Clayton et al., 1992). Further, GnRH mRNA in the ovary was
localized to granulosa cells of primary, secondary, and tertiary follicles (Clayton et al.,
1992; Whitelaw et al., 1995). The presence of GnRH-IR mRNA was also reported in
human granulosa-luteal cells (Minaretzis et al., 1995; Olofsson et al., 1995; Kang et al.,
2000). Since then, GnRH receptor expression has been characterized in bovine granulosa
cells and was increased in granulosa cells of small follicles compared to medium and
large follicles (Ramakrishnappa et al., 2003). Gonadotropin releasing hormone receptor
has also been identified in human granulosa-luteal cells, and in bovine oviduct and
endometrium (Peng et al., 1994; Singh et al., 2008). Investigation into the extra-pituitary
presence of GnRH and GnRH-R systems has been an area of interest for reproductive
scientists and as a result there is new information being added continually.
Interestingly, in humans, chimpanzees, horses, sheep, rodents, and cows the
GnRH-IIR has been silenced and is not full-length (Millar, 2003; Morgan et al., 2003;
Pawson et al., 2003; Millar et al., 2004; Morgan et al., 2006). Through ligand-inducedselective signaling, however, signaling of GnRH-II can be accommodated by the GnRHIR and has unique signaling roles to GnRH-I (Maudsley et al., 2004; Millar et al., 2004;
Millar, 2005). Alternatively, there are reports of the possibility of a functional human
GnRH-IIR on chromosome 1 (Van Biljon et al., 2002). Complete sequencing of the
human GnRH-IIR gene revealed that although all three exons were present, there is a
missing nucleotide in the 5’ sequence that could be causing a frame shift, resulting in a
single base change in an arginine codon in exon 2 that gives rise to a stop codon
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(Faurholm et al., 2001; Millar, 2003). Millar (2003) provides several explanations for
differing observations surrounding the GnRH-IIR, they are: (1) the GnRH-IIR in humans
has become nonfunctional and its function is now served by the GnRH-IR, (2) the
frameshift and stop codon are repaired during translation and post-translationally by
mRNA editing mechanisms (Morgan et al., 2003), and (3) a partial GnRH-IIR is present
and functional and may serve to regulate the GnRH-IR.

GnRH REGULATION OF REPRODUCTION

Gonadotropin releasing hormone is a pivotal player in the regulation of the
reproductive system. Originally known for its actions in the upper portion of the HPG
axis in its stimulation of gonadotropin release from the anterior pituitary, GnRH also has
direct paracrine and autocrine actions at several local reproductive tissues. The
subsequent sections aim to highlight the ways in which GnRH regulates reproduction
through the HPG axis both locally and systemically.

GnRH actions on follicular development

At the level of the ovary, GnRH has been reported to have both stimulatory and
inhibitory actions (Sharpe, 1982; Janssens et al., 2000). Gonadotropin releasing hormone
antibody infusion into prepubertal porcine ovarian tissue resulted in decreased numbers
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of follicles greater than 0.5 mm in diameter, and increased incidence of atresia in follicles
with greater than 4 layers of granulosa cells (Patton et al., 1991).
Other methods of GnRH administration have been reported to impact
folliculogenesis through direct ovarian actions or via regulation of LH release. When
heifers were injected (i.m.) with small doses (5 µg and 10 µg) of GnRH agonist twice
daily for three weeks, pulsatile secretion of LH was suppressed and development of
follicles beyond 9 mm was inhibited, causing anovulation as a result of reduced estradiol
production and inadequate stimulation of the preovulatory LH (Gong et al., 1995). When
the GnRH agonist treatment was stopped dominant follicles reached ovulatory size and
ovulated (Gong et al., 1995).
Deslorelin (a GnRH analog) implants of 700 µg and 2100 µg delayed selection of
the third dominant follicle in non-lactating Holstein cows implanted four days after
ovulation, and the severity of the delay was increased with the increased dose implants
(Rajamahendran et al., 1998). Additionally, the number of medium antral follicles was
reduced in the 700 µg and 2100 µg Deslorelin implanted groups compared to controls.
Overall the 700 µg Deslorelin group had the fewest large antral follicles compared to
control cows between days 13 and 19 following ovulation (Rajamahendran et al., 1998).

GnRH actions on steroid hormone production

Recall that GnRH is a critical player of the HPG axis and stimulates the synthesis
and secretion of gonadotropins at the level of the anterior pituitary, however, there are
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several reports of GnRH actions on steroidogenesis in the ovary (Janssens et al., 2000).
This section is dedicated to elaborating the direct ovarian actions of GnRH as they pertain
to steroid hormone production. Gonadotropin releasing hormone is believed to exert its
direct effects on its own or in combination with other modulators, and in doing this there
is activation of signaling pathways that cause both stimulatory and inhibitory actions on
steroidogenesis (Hsueh et al., 1980; Hsueh and Jones, 1982; Jones and Hsueh, 1982).
Gonadotropin releasing hormone was reported to inhibit steroidogenesis in
granulosa cells and luteal cells in culture (Clayton et al., 1979). In cultured rat granulosa
cells, the use of a GnRH analog inhibited the induction of LH receptors via FSH and the
aromatase enzyme ultimately blocking ovarian growth (Hsueh et al., 1980). Further,
GnRH agonist treatment resulted in suppression of FSH and LH receptors (Piquette et al.,
1991; Tilly et al., 1992), and enzymes involved in the steroidogenic pathway like StAR,
P450 scc, and 3βHSD (Sridaran et al., 1999a; Sridaran et al., 1999b). Ovarian FSH
receptors decreased by 25% in intact rats treated daily with 3 to 30 ng of GnRH agonist,
and were decreased by 64% after daily treatments with 100 ng of GnRH agonist (Seguin
et al., 1981).
Gonadotropin releasing hormone agonists added in vitro had dose-dependent
stimulatory effects on aromatase activity, the enzyme responsible for the conversion of
androgens to estrogens (Janssens et al., 2000). Within in vitro human granulosa-luteal
cells, GnRH-I mRNA abundance was down regulated by estradiol-17β (Nathwani et al.,
2000; Kang et al., 2001a). When a GnRH agonist was added to cultured bovine
granulosa cells at a concentration of 200 ng/mL, it had a stimulatory effect on estradiol
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production, however, at concentrations of 500 ng/mL and 1000 ng/mL, it had an
inhibitory effect on estradiol production (Ramakrishnappa et al., 2005).
Beef cows that did not exhibit estrus prior to FTAI treated with intramuscular
injections of GnRH (5 µg), every eight hours from the time of prostaglandin
administration (hour 0) to 33 hours, had decreased abundance of mRNA for 3βHSD and
P450scc in granulosa cells, indicating decreased function of the steroidogenic pathway
(Larimore et al., 2016). Additionally, Buserelin added to culture luteal cells resulted in
decreased progesterone secretion (Milvae et al., 1984).

GnRH actions on expression of estrus, fertilization and conception rates

A 5 µg dose of GnRH elicited an LH pulse similar to a physiological pulse
(McLeod et al., 1984; Ginther and Beg, 2012), and increased LH pulsatility increased
estradiol concentrations (Fortune et al., 2001). Beef cows injected with GnRH (5 µg)
intramuscularly every 8 hours from the time of prostaglandin injection (hour 0) to 33
hours after, had elevated estradiol concentrations at hours 7, 8, and 16 (Larimore et al.,
2016), this was thought to occur via GnRH inducing increased LH pulsatility. However,
after continued 8-hour interval injections past the 16 hour mark estradiol concentrations
declined, indicative of a hyperstimulation (Larimore et al., 2016). Estradiol is the
primary signal to the hypothalamus to initiate the expression of estrus and it does this
through feedback mechanisms of the HPG axis (Vailes et al., 1992; Diskin and Sreenan,
2000).
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A meta-analysis conducted using over 10,000 beef females reported that animals
that exhibit estrus prior to fixed-time artificial insemination had greater conception rates
compared to animals that did not exhibit estrus (Richardson et al., 2016). Furthermore,
supplementation of a single small dose of GnRH (5 µg) at time of CIDR
removal/prostaglandin injection using a 7-day CO-Synch + CIDR protocol shortened the
interval to estrus among heifers and increased expression of estrus (Rich et al., 2018a).
Additionally, in a recent study, supplementation with small doses of GnRH (5 µg) at
CIDR removal/prostaglandin injection and again 12 hours later did not impact circulating
concentrations of estradiol or expression of estrus, but did increase conception rates to
FTAI (Rich et al., 2018b).
Regarding fertilization, GnRH has both direct and indirect effects. Gonadotropin
releasing hormone indirect effects on fertilization have been reported at the level of the
endometrium. Expression of estrogen receptor alpha was increased in cultured luteal
phase bovine endometrium with GnRH, suggesting a role in endometrial responsiveness
to estradiol and associated uterine receptivity and maintenance of pregnancy (Singh et al.,
2009). Gonadotropin releasing hormone has been reported in ovarian follicular cells and
follicular fluid of many species as well as in the uterus (Ying et al., 1981; Aten et al.,
1987; Ireland et al., 1988; Oikawa et al., 1990; Singh et al., 2008), therefore spermatozoa
that are introduced into the tract during breeding or artificial insemination are likely to
encounter GnRH. In humans, GnRH was reported to increase spermatozoa-zona
pellucida interaction and facilitate increased binding (Morales and Llanos, 1996).
Additionally, cleavage rates were increased among bovine oocytes cultured with GnRH
agonists (Funston and Seidel, 1995).

41
GnRH actions on follicle atresia and apoptosis in reproductive cells

Gonadotropin releasing hormone has been reported to have direct effects on
apoptosis in the ovary. The initiation of apoptosis in granulosa cells is one of the earlier
signs of atresia (Tilly and Hsueh, 1993a; Yuan and Giudice, 1997). Furthermore,
research exists that supports the direct effects of GnRH in regulating follicular atresia and
induction of cellular apoptosis (Labrie et al., 1982; Hsueh et al., 1984; Piquette et al.,
1991; Billig et al., 1994; Whitelaw et al., 1995; Motomura, 1998; Sridaran et al., 1998).
Increased abundance of GnRH-IR mRNA has been found in atretic follicles of rats during
the follicular phase (Whitelaw et al., 1995) and in vitro studies with GnRH inhibited
DNA synthesis and stimulated the induction of apoptosis, with the actions of GnRH
being confined to the rat granulosa cells (Billig et al., 1994; Saragueta et al., 1997). This
stimulatory effect of GnRH in inducing apoptosis has also been observed in porcine and
human granulosa cells (Zhao et al., 2000). By way of mediating proteolytic pathways of
the GnRH-I receptor, both GnRH-I and GnRH-II were reported to induce apoptosis in
human immortalized granulosa cell culture lines (Hong et al., 2008).
The actions of GnRH inducing apoptosis is not limited to the ovary. Bovine
endometrial explants of the follicular phase endometrium cultured with increasing doses
of Buserelin (GnRH agonist), were reported to have increased expression of key factors
involved in the apoptotic pathway. At the cellular level, Buserelin treatment induced
apoptosis in endometrial epithelial cells (Singh et al., 2011b).
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REGULATION OF GnRH

In our discussions of the HPG axis hypothalamic GnRH is regulated by many
factors of hypothalamic, pituitary, and ovarian origin. However, GnRH has also been
characterized locally in various reproductive tissues. The following sections serve to
provide background knowledge of hypothalamic and local (ovarian) regulation of GnRH.
We will cover how GnRH may be regulating its own release/actions as well as how some
other factors may be regulating GnRH.

GnRH within the Hypothalamus

Immunoreactive GnRH neurons were observed in a rostral-caudal distribution
from the septum to medial portions of the basal hypothalamus, with the majority of cell
bodies located in the POA in both heifers and cows (Dees and McArthur, 1981; Cardoso
et al., 2015). Direct kisspeptin stimulation of GnRH cells occurs from the population of
kisspeptin cells located in the dorsolateral POA and that kisspeptin cells of the ARC
likely regulate GnRH cells indirectly (Backholer et al., 2009). Orexin and kisspeptin are
positive regulators of the HPG axis and both of these cell types have been demonstrated
to have direct input to GnRH cells in various species (Backholer et al., 2009).
After stimulation, the secretory target of GnRH neurons is a specialized vascular
structure known as the primary portal plexus, that serves as a vascular connection
between the neurosecretory cells of the hypothalamus and the anterior pituitary gland, of
the hypothalamo-hypophyseal portal system in the median eminence (Plant, 2015).
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Gonadotropin releasing hormone is released from GnRH neurons into the specialized
portal vasculature where it can enter the anterior pituitary gland to bind receptors on
gonadotrope cells and cause the release of gonadotropins. Gonadotropin releasing
hormone can also regulate its own secretion in what is termed an ultra-short negative
feedback loop, where GnRH secreted from GnRH neurons feeds back to inhibit further
secretion of GnRH (McCann and Ramirez, 1964; Senger, 2003).
Additionally, in the hypothalamus RF-amide related peptide 3 (RFRP3), the
mammalian equivalent to the avian gonadotropin inhibitory hormone (GnIH; Tsutsui et
al. (2000)), can inhibit the activity of mammalian GnRH neuronal cells (Murakami et al.,
2008; Anderson et al., 2009; Ducret et al., 2009; Kadokawa et al., 2009; Bentley et al.,
2010; Son et al., 2016; Wilsterman et al., 2019). Gonadotropin releasing hormone
signaling can be assessed by analyzing cAMP and by assessing the phosphorylation of
downstream mediators of GnRH signaling: ERK and p38 (Torrealday et al., 2013). RFamide related peptide 3 when cultured with mouse GnRH neuronal cell lines eliminated
stimulatory effects on the phosphorylation of p38 and ERK (Son et al., 2016). In
ovariectomized rats subjected to an estradiol plus progesterone surge induction protocol,
chronic infusion with RFRP3 caused a dose-dependent inhibition of approximately 55%
of GnRH neurons at the LH surge peak compared to non-infused controls (Anderson et
al., 2009).
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GnRH within the Ovary

Using iodinated GnRH agonist, Reeves et al. (1980) demonstrated specific
binding to a single class of high-affinity sites in both the anterior pituitary and ovarian
homogenates. The specificities of the GnRH receptors were similar in the anterior
pituitary and ovary. The presence of specific ovarian GnRH receptors raises the
possibility that GnRH secreted locally could be involved in the control of ovarian
activity.
In a study by Peng et al. (1994) using human granulosa-luteal cells, GnRH
increased GnRH mRNA abundance at low doses, but had no effect or a slight inhibitory
effect on GnRH transcript abundance at greater doses. In rats, granulosa cell GnRH
transcript abundance was increased when GnRH (1.18 μg/mL) was added to the culture
medium (Olofsson et al., 1995). This relationship was also reported for GnRH-II, where
GnRH-II differentially regulated its own transcript abundance; treatment with GnRH-II,
resulted in significant decreased of both GnRH-I and GnRH-I receptor mRNA abundance
in human granulosa-luteal cells (Kang et al., 2001b). In a study evaluating mouse ovaries
during the estrous cycle the presence of GnRH-I, GnRH-IR, and RFRP3 were localized
to the GC of antral follicles during proestrus and estrus and the luteal cells during
diestrus. Specifically, an increase in RFRP3 concentration coincided with a decline in
CL activity and initiation of follicular growth (Singh et al., 2011a).
Labeling of GnRH-I receptors by injection of iodinated GnRH agonist in adult
rats revealed staining on follicular and thecal cells of mature follicles; additionally, ova
and follicular fluid were consistently labeled (Labrie et al., 1982). Similar labeling was
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observed in growing follicles, but not in primordial follicles (Labrie et al., 1982).
Furthermore, in this same study the authors reported a decrease in GnRH-I receptor
protein in the week prior to the first ovulation, they speculated that this decrease could be
permissive of a gradual increase in ovarian responsiveness, supporting the idea that
GnRH may have a regulatory role on follicular development and growth (Labrie et al.,
1982). In the human ovary, there was no immunodetection of GnRH-I, GnRH-II or the
GnRH-IR in primordial to early antral follicles, however, both forms of GnRH and their
common receptor were localized to the granulosa cell layer of preovulatory follicles,
granulosa luteal cells of the corpus luteum, and the ovarian surface epithelium (Choi et
al., 2006).
Gonadotropin releasing hormone-I receptor protein was detected in the plasma
membrane and perinuclear zone of germ cells during meiosis and folliculogenesis in the
Rock Dove (Olea et al., 2020). In the rat ovary GnRH-IR mRNA and protein was
strongly expressed in oocytes, columnar GC of early follicles, and in the GC of late
growing follicles. It was weakly expressed in theca cells and stroma cells of late growing
follicles, and there was no expression detected in squamous GC (Mo et al., 2010).
In a study analyzing the presence of GnRH-I in the ovary and hypothalamus of
chickens before and after sexual maturation, GnRH-I mRNA was decreased in the ovary
compared to the hypothalamus after sexual maturation (Chen et al., 2019). Furthermore,
GnRH-I mRNA abundance was reported to be greater in theca cells compared to
granulosa cells (Chen et al., 2019).
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GnRH

Granulosa cells

Rats (Mo et al.,
2010); Mouse
(Torrealday et
al., 2013); Rock
dove perinuclear
zone (Olea et al.,
2020); Mouse
(Singh et al.,
2011a)

Oocyte

Interna layer of
preovulatory
follicles in
premenopausal
women (Choi et al.,
2006); Late growing
follicles of rats (Mo
et al., 2010); Mouse
(Singh et al., 2011a);
Chicken (Chen et al.,
2019)

Theca cells

Late growing
follicles of
rats (Mo et
al., 2010)

Stroma

x

Nerve
Fibers

Reported Ovarian Localization

Preovulatory follicles in
premenopausal humans
(Choi et al., 2006);
Columnar cells of early
follicles and in late growing
follicles in rats (Mo et al.,
2010); Normal and
cumulus cells in mice
(Torrealday et al., 2013);
Mouse (Singh et al.,
2011a); Chicken (Chen et
al., 2019)

Table 1. Reported ovarian localization of GnRH.

x

Vessels

Developing CLs
in human and
primate (Choi et
al., 2006);
Mouse (Singh et
al., 2011a)

Corpus Luteum

x

Arterioles
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α-MSH within the Hypothalamus

The pro-hormone pro-opiomelanocortin (POMC) is the precursor molecule to key
peptides that play important roles in the regulation of appetite and obesity (Pritchard et
al., 2002). The precursor POMC protein contains three main regions: (1) the ACTH
(adrenocorticotropic hormone) sequence that is cleaved in the hypothalamus to ultimately
generate α-MSH (melanocyte stimulating hormone), (2) the C-terminal β-LPH (lipotropin
hormone) region that is cleaved to generate 𝛾-LPH, β-endorphin, and β-MSH, and (3) the
N-terminal 𝛾-MSH containing sequence (Pritchard et al., 2002). The POMC peptide and
its derivatives has been reported to have a strong interrelationship with leptin/kisspeptin
and GnRH, making it of interest to physiologists aiming to understand physiological
mechanisms surrounding nutrition, appetite, and fatness specifically pertaining to the
attainment of puberty and reproduction.
Pro-opiomelanocortin neurons have been reported to have direct synapses with
GnRH neurons in rats (Leranth et al., 1988; Cheung and Hammer, 1995). In rats the
majority of POMC mRNA-containing cells were characterized to be located centrally
within the arcuate nucleus and the median eminence and administration of estradiol
increased POMC mRNA abundance in the rostral ARC region in the absence of
progesterone in ovariectomized female rats, suggesting POMC mRNA transcription
might be primed by estradiol exposure and may affect reproductive behaviors that vary
with hormone concentrations across the estrous cycle (Cheung and Hammer, 1995).
Abundance of POMC mRNA in the ARC is increased in pubertal heifers that gained
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bodyweight at high rates between four and six and a half months of age compared to
heifers that gained at lower rates (Allen et al., 2012).
Post-translational processing of the POMC gene results in the formation of
several products such as ACTH, α-MSH, and β-endorphins (Pritchard et al., 2002).
Specifically, α-MSH, has been reported to stimulate the reproductive hypothalamopituitary-gonadal axis by exciting GnRH neurons at the level of the hypothalamus in
multiple species including mice, rats, sheep and humans (Watanobe et al., 1999;
Backholer et al., 2009; Roa and Herbison, 2012). There were observed increases in LH
secretion in sheep treated with a lateral ventricular infusion of a melanocortin agonist
during the luteal phase of the estrous cycle, and this stimulatory action was speculated to
occur via the activation of kisspeptin cells in the POA (Backholer et al., 2009). In a study
using diestrous mouse brain sections the direct regulation of GnRH neuron excitability by
POMC of the ARC was reported; approximately 70% of the GnRH neurons were
activated by α-MSH (Roa and Herbison, 2012). Due to this relationship with GnRH,
POMC neurons in the ARC, via α-MSH signaling, may be involved in the nutritional
programming of puberty in bovine females. Fibers containing α-MSH were observed to
be in direct opposition to approximately 20% of GnRH neurons (Cardoso et al., 2015). It
has been postulated that orexin and kisspeptin cell types, that have also been
demonstrated to have direct input to GnRH cells, act as conduits for α-MSH feedback
(Backholer et al., 2009; Cardoso et al., 2015). These reports highlight the regulatory
mechanisms of α-MSH at the level of the hypothalamus, and being active in the HPG
axis therefore, the next section will highlight local actions of α-MSH in various species.
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α-MSH within the Ovary

Pro-opiomelanocortin and its derivatives have been reported in the sheep ovary
(Lim et al., 1983), rat and primate ovary (Chen et al., 1986; Jin et al., 1988), human
ovarian tissue (Gallinelli et al., 1995) and porcine granulosa, theca, and luteal cells
(Staszkiewicz et al., 2007a; Staszkiewicz et al., 2007b) and in the placenta of rats, mice,
and humans (Chen et al., 1986). Additionally, MSH has been identified in whole ovarian
homogenate of beef cattle (Cushman, RA-RNA Seq unpublished data). Treatment of 25day old immature female rats with PMSG (gonadotropin) resulted in increases in the
ovarian content of POMC-like mRNA, and POMC-like mRNA content during pregnancy
increased three to four times the levels characterized in immature or normally cycling
animals (Chen et al., 1986). The content of POMC mRNA increased two fold in the
ovary of rodents during pregnancy but was not changed in the uterus (Jin et al., 1988).
The expression of POMC mRNA was greater in ovaries of fertile women compared to
post-menopausal women, and was not detected in corpora lutea (Gallinelli et al., 1995).
Ovarian presence of POMC and α-MSH, specifically at the level of the ovarian
follicle, has been characterized during different developmental stages. Immunoreactivity
was observed in the granulosa cells and theca interna cells of vitellogenic (mature) but
not primordial (immature) follicles on the African lung fish (Masini et al., 1997).
Additionally, in amphioxus α-MSH was found in the primary oocytes of small and large
growth stages of the ovary (Fang et al., 2008). The differences in POMC and α-MSH in
various reproductive tissues and during different reproductive stages is suggestive of a
functional role within the reproductive tract of females.
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POMC /
α-MSH

Cytoplasm of GC in
vitellogenic
follicles in African
lung fish (Masini
et al., 1997) Sheep
(Lim et al., 1983);
Rat (Chen et al.,
1986); Human
(Gallinelli et al.,
1995); Porcine
(Staszkiewicz et
al., 2007a)

Granulosa cells

Oocyte

Theca cells

x

Stroma

x

Nerve
Fibers

x

Vessels

Porcine
(Staszkiewicz
et al., 2007b)

Corpus
Luteum

x

Arterioles

Reported Ovarian Localization

Amphioxus
(Fang et
al., 2008)

Porcine
(Staszkiewicz et
al., 2007a);
Interna layer of
vitellogenic
follicles in
African lung fish
(Masini et al.,
1997)

Table 2. Reported ovarian localization of POMC and its derivative α-MSH.
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NPY within the Hypothalamus

Another factor at the level of the hypothalamus that regulates GnRH is
neuropeptide Y (NPY). Neuropeptide Y is a 36-amino acid peptide first demonstrated in,
and isolated from porcine brain and is suspected to only be present in nerve cells
(Tatemoto et al., 1982). Greatest concentrations of NPY are found in the hypothalamus
(Wojcik-Gladysz and Polkowska, 2006) and more specifically NPY neurons are located
in the arcuate nucleus and approximately 50% of NPY axons apposed GnRH neurons
within the ARC of mice (O'Donohue et al., 1985; Turi et al., 2003; Alves et al., 2015).
One of the most well accepted roles of NPY is in the stimulation of feed intake (DiBona,
2002; Grove and Smith, 2003; Williams et al., 2004). Concentrations of NPY are
increased in undernourished animals (McShane et al., 1992). The proportion and
magnitude of NPY fibers in apposition to GnRH neurons in the mediobasal hypothalamus
were reduced in high-gain heifers (Alves et al., 2015). Contradicting reports on the effect
of NPY on GnRH and gonadotropin release exist. In a study investigating regulation of
GnRH by NPY at the level of the median eminence during the preovulatory period in
ewes, NPY increased GnRH and facilitated the release of gonadotropins, while an NPY
antagonist decreased GnRH (Advis et al., 2003). Specifically, NPY and GnRH were
released in a parallel manner leading up to the preovulatory surge of LH in synchronized
sheep (Advis et al., 2003). Adversely, in many other studies investigating the effect of
NPY on GnRH and gonadotropin secretion in sheep and cattle via infusion into the brain,
GnRH release and LH concentrations were suppressed, there was complete cessation of
LH pulses, and decreased pulse frequency and amplitude of GnRH (Barker-Gibb et al.,
1995; Gazal et al., 1998; Thomas et al., 1999; Estrada et al., 2003; Morrison et al., 2003).
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There is ultrastructural evidence of synaptic connections between NPY and GnRH
neurons in the POA of both rats and sheep (Karsch et al., 1989; Tsuruo et al., 1990) as
well as NPY modulation of basal pulsatile LH secretion by actions in the mediobasal
hypothalamic area in sheep (Barker-Gibb et al., 1995). In mice NPY terminals were
identified to be synapsing on GnRH neurons (Turi et al., 2003). In ruminants NPY has
predominantly inhibitory actions on the release of LH irrespective of steroidal influences
(Barker-Gibb et al., 1995; Gazal et al., 1998; Estrada et al., 2003; Morrison et al., 2003),
this response is largely due to inhibition of GnRH release (Gazal et al., 1998). In cattle
and sheep, NPY inhibits the release of GnRH/LH in the presence and absence of estradiol
(McShane et al., 1992; Thomas et al., 1999). Further, in a study by Roa and Herbison
(2012) using female mice as the model porcine NPY directly inhibited firing of 45% of
GnRH neurons, while NPY agonist could excite or inhibit GnRH neurons. Additionally,
in a study by Advis et al. (2003) their results support NPY as the driver of downstream
events leading to the preovulatory LH surge. Neuropeptide Y affects binding of GnRH to
its receptor in gonadotropes of rats (Leblanc et al., 1994).
Furthermore, increased bodyweight gain during heifer development accelerates
puberty attainment, concurrent with reciprocal changes in hypothalamic NPY release
(Cardoso et al., 2014). Heifers that gained at an accelerated rate had reduced overall
NPY expression in the arcuate nucleus (Alves et al., 2015). This is supportive of a
regulatory role of NPY that may modulate puberty attainment. Overall, interactions
between NPY and GnRH at the level of the hypothalamus are important in regulation of
reproduction in terms of puberty attainment as well as the timing and magnitude of
preovulatory GnRH release and LH surge.
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NPY within the Ovary

Neuropeptide Y is widely distributed throughout the body, and localized to both
central and peripheral nervous systems (O'Donohue et al., 1985), it is colonized by
norepinephrine and well known for its vasoconstrictive properties which have also been
demonstrated in studies with rabbit ovarian arteries (Jørgensen, 1991). Neuropeptide Y
has been reported in ovarian tissues of humans, cattle, sheep, European bison, and pigs
(Owman et al., 1986; Hulshof et al., 1994; Keator et al., 2010; Skobowiat et al., 2013;
Sirotkin et al., 2015). Immunoreactive nerve fibers for NPY have been localized in
tissues of the reproductive tract in multiple species, and specifically in the cow (Hulshof
et al., 1994; Majewski et al., 1995). Additionally, NPY has been identified in whole
ovarian homogenate of beef cattle (Cushman, RA-RNA Seq data).
Hulshof et al. (1994) studied distribution of NPY in bovine ovaries from 3 months
of gestation up to and including puberty, and from normal cyclic cows and heifers at
three stages of follicular development. Immunoreactive fibers for NPY increased with
age until nine months after birth and thereafter did not change noticeably. This is
particularly of interest as bovine females experience periods of development and
senescence of germ cell development during gestation (Erickson, 1966a; Erickson,
1966b). Evidence of immunoreactivity for NPY was localized to arteries/arterioles of the
ovary, nerve fibers in the stroma near preantral follicles, and in the theca externa of antral
follicles. There were no distinct differences in NPY immunoreactivity in bovine ovarian
tissue at different stages of the ovarian cycle (Hulshof et al., 1994).
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Use of immunocytochemistry methods revealed that NPY inhibited proliferation
and promoted apoptosis in porcine luteinized granulosa cells (Sirotkin et al., 2015),
indicating a potential role of NPY in follicular development, as the balance between
proliferation and apoptosis is determinant of the fate of an ovarian follicle (Sirotkin,
2010). Immunohistochemistry revealed that NPY antigen was localized to cells within
ovarian follicles and the CL, nerve fibers of the ovarian stroma, and in the vessels of the
ovarian hilus of sheep. Within the follicle, NPY antigen was localized to nerves and
vessels within the theca interna layer and strong staining was observed in the granulosa
cells of ovine antral follicles, nerve fibers were also detected in the vessels of the ovarian
hilus and in the ovarian stroma. In the CL, NPY was localized to large luteal cells
(Keator et al., 2010). In European bison, NPY immunoreactive nerve fibers were found
in bundle like structures surrounding the ovarian arteries, innervation was present in both
the cortical and stromal regions (Skobowiat et al., 2013). In vivo infusion of NPY into
the transplanted ovine ovary bearing an 11 day old CL increased ovarian blood flow via
increased oxytocin concentrations (Keator et al., 2010). Nerve fibers for NPY were
detected in relation to blood vessels, nerve fibers close to oocytes, and primordial
follicles from fetuses at 40 weeks of gestation. In mature ovaries, NPY immunoreactive
nerve fibers were detected in proximity to arteries and stromal tissue, and concentrations
of NPY were greater on a per gram basis in mature versus fetal human ovaries (Jørgensen
et al., 1996).
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NPY

Small and
large antral
follicles ovine
and porcine
(Keator et al.,
2010);
Porcine
luteinized
granulosa
cells (Sirotkin
et al., 2015)

Granulosa
cells
Oocyte

Theca cells
Bovine near
preantral follicles
(Hulsof et al.,
1994); Human
mature ovary
(Jorgenson et al.,
1996); Porcine
(Keator et al.,
2010); Bison
(Skobowiat et al.,
2013)

Stroma

Hilus, theca cell layer, ovine
and porcine (Keator et al.,
2010); Bison (Skobowiat et
al., 2013); Bovine ovarian
medulla and tunica
adventitia of arterioles
(Hulshof et al., 1994); Close
to oocyte humans
(Jorgenson et al., 1996);
Human ovary and fallopian
tube (Owman et al., 1986)

Nerve Fibers

Ovine
(Keator et
al., 2010);
Human
immature
and
mature
ovary
(Jorgenson
et al.,
1996)

Vessels

Ovine
and
porcine
(Keator
et al.,
2010)

Corpus
Luteum

Bovine tunica
adventitia and wall
of arterioles
(Hulsof et al.,
1994); Ovine and
porcine stroma
(Keator et al.,
2010); Bison
(Skobowiat et al.,
2013); Rabbit
ovarian artery
(Jorgensen, 1991)

Arterioles

Reported Ovarian Localization

Human
immature
ovary
nerve
fiber close
to oocyte
(Jorgenson
et al.,
1996)

Bovine
externa layer
of antral
follicles
(Hulsof et al.,
1994); Within
nerves and
vessels here in
ovine (Keator
et al., 2010)

Table 3. Reported ovarian localization of NPY.
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AMH within the Hypothalamus

Anti-Müllerian hormone (AMH) is a glycoprotein of the transforming growth
factor family (Cate et al., 1986) and was initially identified for its role in the regression of
Müllerian ducts in male rabbit embryos (Jost, 1953). Since then, AMH has been
characterized in most mammals. In addition to its role in sexual differentiation, evidence
of the role of AMH in ovarian follicular development (Gruijters et al., 2003) and ovarian
reserve parameters (van Rooij et al., 2002) has been well-characterized (Barbotin et al.,
2019).
Extragonadal presence of AMH and its receptor has been characterized in mice,
rats, cattle, and humans (Bedecarrats et al., 2003; Cimino et al., 2016; Garrel et al., 2019;
Kereilwe and Kadokawa, 2020). The extragonadal effects of AMH on the HPG axis
were evaluated in mice and humans. A subset of GnRH neurons in mice and humans
express the AMH receptor, and AMH strongly activated GnRH neuron firing in mice.
Anti-Müllerian hormone increased GnRH-dependent LH pulsatility and secretion,
supportive of a central action of AMH on GnRH neurons (Cimino et al., 2016). In
addition to the AMH receptor, GnRH neurons in mice and humans also express AMH
(Malone et al., 2019).
Using RT-PCR and western blot analyses in brain tissues collected from post
pubertal heifers AMH and AMH-R mRNA and protein were detected in the POA, ARC,
and ME of the hypothalamus where GnRH neurons are located (Clarke et al., 1987;
Jansen et al., 1997). Using triple immunofluorescent IHC the authors characterized that
most cell bodies or fibers of GnRH neurons were AMH and AMH-R positive.
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Furthermore, IHC revealed that 75-85% of cell bodies and fibers of GnRH neurons were
positive for both AMH and AMH-R in the POA, ARC, and the ME (Kereilwe and
Kadokawa, 2020).
It was discovered that GnRH pulsatility impacts AMH receptor expression on
gonadotrope cells, specifically increased GnRH pulsatility increased AMH receptor
transcript abundance in mice gonadotrope cells (Garrel et al., 2019). Suggestive of a
regulatory role of GnRH on gonadotrope AMH receptor expression. Furthermore, AMH
mRNA expression was characterized in rat gonadotrope cells and activated gonadotropin
gene transcription (Bedecarrats et al., 2003). These results are suggestive of the fact that
AMH may modulate the HPG axis at more than one level.

AMH within the Ovary

Anti-Müllerian hormone is produced by granulosa cells in the ovary and is
indicative of the ovarian reserve, and as such is a determinant of female reproductive
potential (van Rooij et al., 2002), it also is a regulator of folliculogenesis (Gruijters et al.,
2003; Weenen et al., 2004). The greatest abundance of AMH transcript was observed in
granulosa cells of secondary preantral and small antral follicles (less than or equal to four
mm) in cycling women (Weenen et al., 2004). Anti-Müllerian hormone is an important
factor in inhibiting follicular growth meaning its presence could play an important role in
preserving and prolonging fecundity (Yang et al., 2017; Barbotin et al., 2019).
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Pieces of fetal bovine ovarian cortex were cultured with or without AMH and
their response to the addition of an activator was assessed. There were dose-dependent
inhibitory effects of AMH on primordial follicles activation and primary follicle growth
(Yang et al., 2017). Another measure correlating to female fertility is antral follicle count
(Ireland et al., 2008). In a study aiming to characterize differences in AMH between low
and high antral follicle count (AFC) cows, the authors concluded that the granulosa cells
of the high AFC group had the ability to produce more AMH in culture than those in the
low AFC group (Sakaguchi et al., 2019). Heifers with greater AFC have increased AMH
concentrations and have overall better fertility than low AFC heifers (McNeel and
Cushman, 2015).
Circulatory concentrations of AMH are indicative of the ovarian reserve, and
AMH has been shown to regulate follicular growth. Regulation and control of follicular
growth is crucial to prolonged female fecundity. Culture of human granulosa luteal cells
obtained from normal cycling women revealed that LH treatment reduced AMH receptor
expression (Pierre et al., 2013). The studies summarized provide evidence that AMH
plays a critical role in modulating folliculogenesis to preserve and prolong female
reproductive potential.
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AMH

Granulosa cells

x

Oocyte

Bovine fetal
ovaries (Yang
et al., 2017)

Theca cells

x

Stroma

x

Nerve
Fibers

x

Vessels

x

Corpus
Luteum

x

Arterioles

Reported Ovarian Localization

Small growing follicles of
mice (Gruijters et al., 2003);
Human preantral and small
antral follicles (Weenen et
al., 2004); Mice growing
follicles (Kevenaar et al.,
2006); GC and cumulus cells
of small antral follicles in
fetal bovine ovaries (Yang et
al., 2017)

Table 4. Reported ovarian localization of AMH.
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SUMMARY

In summary, GnRH-I, GnRH-II, and their receptors have been the focus of many
scientists. Two forms of GnRH (GnRH-I and GnRH-II) are present in mammals. They
play important roles in regulation of the HPG axis at various levels where they impact
steroidogenesis and reproduction. The GnRH-II peptide and receptor are silenced and
functionally inactivated in cattle and other mammalian species, even though the peptide
and receptor have been characterized in these species. This has led to various hypotheses
and questions; is GnRH-II working through the GnRH-IR? Why is GnRH-II present if it
is silenced?
A lot of the existing data has characterized extra-pituitary actions of the GnRH
forms; however, much remains to be elucidated regarding function at the level of the
ovary. Advanced understanding in these areas can help improve how beef females are
managed to improve overall reproductive performance. The subsequent chapters will
present information on three studies investigating systemic and local actions of GnRH in
beef cattle.
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CHAPTER 2
SUPPLEMENTAL GnRH USED IN SYNCHRONIZATION PROTOCOLS AMONG
BEEF COWS AND HEIFERS
ABSTRACT
Previous studies evaluating single and multiple GnRH injections at time of CIDR
removal/prostaglandin injection using the 7-day CO-Synch + CIDR protocol have
reported decreased interval to estrus and increased expression of estrus, or increased
conception rates, respectively. Thus, the objective of these studies was to compare the
effects of supplementing GnRH at prostaglandin injection on expression of estrus and
conception rates in beef cows and heifers synchronized with different protocols. In study
1, beef cows (n = 161) and heifers (n = 1803) from 16 herds over three years were
synchronized using the 7-day CO-Synch + CIDR fixed time AI (FTAI) protocol and were
randomly assigned to receive one of three treatments at prostaglandin injection [0 µg
GnRH (0); 5 µg GnRH (5); or 5 µg at prostaglandin injection and 5 µg 12 h later (5+5)].
In study 2, beef cows (n = 656) and heifers (n = 4552) from 24 herds over three years
were synchronized using the 7-day CO-Synch + CIDR FTAI protocol or the MGA-PG
FTAI heifer protocol (MGA) and were randomly assigned to receive one of two
treatments at prostaglandin injection [0 µg GnRH (0) or 5 µg GnRH (5)]. Expression of
estrus and conception rates were analyzed using the GLIMMIX procedure of SAS with
treatment as an independent variable and herd as a random effect. There was no effect of
treatment on expression of estrus (P=0.38), FTAI conception rates (P=0.85), or breeding
season conception rates in either study. In study 1, there was an effect of estrus (P <
0.01), age (P < 0.01), and a tendency for a treatment × age interaction (P = 0.07).
Animals that exhibited estrus prior to FTAI had increased conception rates compared to
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those that did not, and cows had increased conception rates compared to heifers. Within
the 5 µg treatment, cows tended to have increased FTAI conception rates compared to
heifers. In study 2, there was an effect of protocol on estrus (P < 0.01) and breeding
season pregnancy rates (P < 0.01), where the MGA protocol had increased estrus
expression and increased breeding season pregnancy rates. In conclusion, estrus
expression increased pregnancy success, but supplementation with 5 or 5+5 µg of GnRH
at prostaglandin injection did not improve estrus response or conception rates in beef
cows and heifers regardless of protocol.

INTRODUCTION

The first use of artificial insemination dates back to the 1700s with the first
successful insemination in a dog and the U.S. experienced major growth in the use of AI
in the 1940s (Reviewed by Foote, 2010). However, for various reasons beef producer
adoption of this technology remains low with approximately eight percent of all beef
operations utilizing AI (Whittier, 2010). Some of the main reasons cited for this low
adoption is the belief that natural service is easier and cheaper, and that AI requires more
time and labor (Lima et al., 2010; Whittier, 2010). To address the time and labor
concerns fixed-time AI protocols were developed, specifically there are protocols
designed for beef cows and heifers that are updated annually. Therefore, to have
increased adoption of AI within the beef industry, synchronization protocols need to be
easy to administer, effectively synchronize estrus and induce ovulation, and contribute to
increased pregnancy success rates (Reviewed by Smith et al., 2012).
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Cattle that exhibit estrus before FTAI had increased estradiol concentrations and
conception rates compared to those that did not (Perry and Perry, 2008; Richardson et al.,
2016). Variations in interval to estrus, expression of estrus, and pregnancy success have
been hindrances to the adoption of FTAI protocols (Roche and Boland, 1991; Bo et al.,
1994). Therefore, it is critical to improve estrus expression to these FTAI protocols to
improve conception rates.
Estradiol is the primary signal to the hypothalamus to initiate the expression of
estrus and it does this through feedback mechanisms of the HPG axis (Vailes et al., 1992;
Diskin and Sreenan, 2000). A 5 µg dose of GnRH elicited an LH pulse similar to a
physiological pulse (McLeod et al., 1984; Ginther and Beg, 2012), and increased LH
pulsatility increased estradiol concentrations (Fortune et al., 2001). Beef cows injected
with GnRH (5 µg) intramuscularly every 8 hours from the time of prostaglandin injection
(hour 0) to 33 hours after, had elevated estradiol concentrations at hours 7, 8, and 16
(Larimore et al., 2016). The observed increases in estradiol concentrations were
hypothesized to occur via GnRH inducing increased LH pulsatility. However, after
continued 8-hour interval injections past the 16 hour mark estradiol concentrations
declined, indicative of a hyperstimulation (Larimore et al., 2016).
Furthermore, in a study administering supplementation of a single small dose of
GnRH (5 µg or 10 µg) at time of CIDR removal/prostaglandin injection using a 7-day
CO-Synch + CIDR protocol, the 5 µg treatment shortened the interval to estrus among
heifers and increased expression of estrus, while the 10 µg treatment had fewer animals
in estrus compared to 5 µg and control animals (Rich et al., 2018a). Additionally, in a
recent study, supplementation with small doses of GnRH (5 µg) at CIDR
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removal/prostaglandin injection and again 12 hours later (5+5 µg) or with a single 10 µg
dose, neither treatment impacted circulating concentrations of estradiol or expression of
estrus, but the 5+5 µg treatment did increase conception rates to FTAI compared to both
the 10 µg dose and control animals (Rich et al., 2018b). Conclusions from these studies
taken together, were that the 5 and 5+5 µg treatments likely contributed to more LH
pulsatility, whereas the 10 µg treatment may have been overstimulating and potentially
negatively impacting estradiol production.
Therefore, the objective of this study was to determine if supplementation of
small doses of GnRH (0, 5, or 5+5 µg) following prostaglandin injection in two different
FTAI synchronization protocols would impact expression of estrus or pregnancy success
in beef cows and heifers. The hypothesis was that supplementing beef cows and heifers
with GnRH at prostaglandin injection would contribute to increased expression of estrus
and/or increased conception rates to FTAI.

MATERIALS AND METHODS

All procedures were approved by the South Dakota State University Institutional
Animal Care and Use Committee.

Experimental Design
In study 1, beef cows (n = 161) and heifers (n = 1803) from 16 herds over three
years were synchronized using the 7-day CO-Synch + CIDR FTAI protocol and were
randomly assigned to receive one of three treatments at prostaglandin injection [0 µg
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GnRH (0); 5 µg GnRH (5); or 5 µg at prostaglandin injection and 5 µg 12 h later (5+5)].
In study 2, beef cows (n = 656) and heifers (n = 4552) from 24 herds over three years
were synchronized using the 7-day CO-Synch + CIDR FTAI protocol or the MGA-PG
FTAI heifer protocol and were randomly assigned to receive one of two treatments at
prostaglandin injection [0 µg GnRH (0) or 5 µg GnRH (5)].

Synchronization Protocols
Study 1: Beef cows and heifers were administered GnRH (100 µg as 2 mL of
Factrel i.m.; Zoetis Animal Health, Madison, NJ) on day -7, and a CIDR (Zoetis Animal
Health, Madison, NJ) was inserted intravaginally. On day 0, PGF2α was administered
(PGF2α; 25 mg as 5 mL of Lutalyse i.m.; Pfizer Animal Health, Madison, NJ), and
CIDRs were removed, at this time animals were administered one of three GnRH
treatments (0 µg, 5 µg, or 5 + 5 µg). Cows and heifers were artificially inseminated 54 ±
2 (heifers) or 63 ± 3 (cows) hours following CIDR removal (FTAI) and administered
GnRH (100 µg as 2 mL Factrel i.m.; Zoetis Animal Health, Madison, NJ).
Study 2: Animals were synchronized using either the CO-Synch (described
above) or MGA protocol and received a treatment of either 0 or 5 µg of GnRH. For the
MGA protocol, beef heifers were fed an MGA supplement starting on day 1 and were fed
for a total of 14 days (0.5 mg MGA/head per day). On day 33, PGF2α was administered
(PGF2α; 25 mg as 5 mL of Lutalyse i.m.; Zoetis Animal Health, Madison, NJ), and at
this time animals were administered one of two GnRH treatments (0 µg or 5 µg). On day
36 (72 hours after GnRH treatment), heifers were artificially inseminated and
administered GnRH (100 µg as 2 mL Factrel i.m.; Zoetis Animal Health, Madison, NJ).
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Detection of Estrus
EstroTect patches (Rockyway Inc., Spring Valley, WI) were applied to the sacral
region of the tail head to assist with detection of estrus. At time of FTAI, EstroTect
patches were evaluated and all animals received a patch score (1 = 0-25% rubbed off; 2 =
25-50% rubbed off; 3 = 50-75% rubbed off; 4 = 75-100% rubbed off). Animals with
patch scores of 1 and 2 were documented as non-estrus/non-activated and patch scores of
3 and 4 were documented as having exhibited standing estrus. One MGA heifer herd
from study 2 did not receive EstroTect patches and, therefore, did not have estrus data
collected. Cows and heifers were maintained separate from bulls for ≥ 10 days or did not
have clean-up bull exposure and were artificially inseminated a second time. All cows
and heifers at their respective units were maintained as single groups throughout the
experiment.

Detection of Pregnancy
Pregnancy diagnoses were conducted approximately 28 and 90 days following
artificial insemination via use of a blood pregnancy test and/or ultrasonography using an
IBEX EVO II ultrasound with a 7.5 MHz transrectal linear probe (E.I. Medical Imaging,
Loveland, CO). This study was conducted over three breeding seasons.

Statistical Analysis
Since expression of estrus and pregnancy status are binomial data, the proportion
of animals in each classification were analyzed as binomial distributions in the
GLIMMIX procedure of SAS. The statistical model for expression of estrus included
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treatment, age (heifer or cow), and the treatment by age interaction. The statistical model
for pregnancy included treatment, estrus, age, and all 2- and 3-way interactions.
Interactions with a significance value of P > 0.20 were removed from the complete model
in a stepwise manner to derive the final reduced model. Differences were significant
when P ≤ 0.05 and a tendency when P > 0.05 but P ≤ 0.10.

RESULTS

Study 1

Expression of Estrus
Expression of estrus was not influenced by treatment (P = 0.63; Figure 3) or a
treatment by age interaction (P = 0.56; Figure 4); however, it was influenced by age (P =
0.0002; Figure 5). Cows had increased expression of estrus compared to heifers (67 ±
6% and 46 ± 3%, respectively).

FTAI Conception Rates
Conception rates to FTAI were not influenced by treatment (P = 0.16; Figure 6),
treatment by estrus (P = 0.39; Figure 7), or treatment by estrus by age (P = 0.32). The
interaction of treatment by age, however, tended to influence FTAI conception rates (P =
0.07; Figure 8). Conception rates were or tended to be similar between cows and heifers
in the 0 µg and 5 + 5 µg treatments. However, among animals administered the 5 µg
treatment, conception rates were increased (P = 0.0006) among cows compared to heifers
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(Figure 8). Furthermore, estrus (P < 0.0001; Figure 9), and age (P = 0.0013; Figure 10)
did impact FTAI conception rates. Animals that exhibited estrus by the time of FTAI had
increased conception rates compared to those that did not (58 ± 5% and 44 ± 5%,
respectively). Cows had increased estrus expression compared to heifers (59 ± 7% and
43 ± 4%, respectively).

Breeding Season Pregnancy Rates
Breeding season pregnancy rates were not influenced by treatment (P = 0.64;
Figure 11) or a treatment by age interaction (P = 0.75; Figure 12). However, breeding
season pregnancy rates were influenced by age (P = 0.0137; Figure 13). Cows had
increased breeding season pregnancy rates compared to heifers (87 ± 5% and 78 ± 4%,
respectively).

69

100
90

P = 0.63

Estrus Expression, %

80
70
61.99

60

53.71

55.41

50
40
30
20
n = 654

n = 656

n = 654

10

0

5

5+5

0

Figure 3. The percentage of animals that had expressed estrus at the time of fixed-time
artificial insemination. Animals either received 5 µg of GnRH at time of prostaglandin
injection (5), 5 µg of GnRH at prostaglandin injection and again 12 hours later (5+5), or
received no exogenous GnRH at time of prostaglandin injection (0) to serve as a control
(P = 0.63).
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Figure 4. Treatment by age interaction on expression of estrus. Animals either received
5 µg of GnRH at time of prostaglandin injection (5), 5 µg of GnRH at prostaglandin
injection and again 12 hours later (5+5), or received no exogenous GnRH at time of
prostaglandin injection (0) to serve as a control (P = 0.56).
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Figure 5. The percentage of heifers and cows that had expressed estrus at the time of
fixed-time artificial insemination (P = 0.0002).
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Figure 6. The percentage of animals that conceived to fixed-time artificial insemination.
Animals either received 5 µg of GnRH at time of prostaglandin injection (5), 5 µg of
GnRH at prostaglandin injection and again 12 hours later (5+5), or received no
exogenous GnRH at time of prostaglandin injection (0) to serve as a control (P = 0.16).
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Figure 7. Treatment by estrus interaction on fixed-time artificial insemination (P = 0.39).
Animals either received 5 µg of GnRH at time of prostaglandin injection (5), 5 µg of
GnRH at prostaglandin injection and again 12 hours later (5+5), or received no
exogenous GnRH at time of prostaglandin injection (0) to serve as a control. There was
no treatment by estrus by age interaction effect on FTAI conception rates (P = 0.32).
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Figure 8. Treatment by age interaction on fixed-time artificial insemination. Animals
either received 5 µg of GnRH at time of prostaglandin injection (5), 5 µg of GnRH at
prostaglandin injection and again 12 hours later (5+5), or received no exogenous GnRH
at time of prostaglandin injection (0) to serve as a control (P = 0.07). abcSuperscripts
differ (P ≤ 0.04), different superscripts with asterisks (*) represent tendencies (P ≤ 0.09).
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Figure 9. Fixed-time artificial insemination conception rates among animals that did and
did not exhibit estrus (P < 0.0001).
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Figure 10. Fixed-time artificial insemination conception rates among heifers and cows (P
< 0.01).
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Figure 11. Breeding season pregnancy rates. Animals either received 5 µg of GnRH at
time of prostaglandin injection (5), 5 µg of GnRH at prostaglandin injection and again 12
hours later (5+5), or received no exogenous GnRH at time of prostaglandin injection (0)
to serve as a control (P = 0.64).
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Figure 12. Treatment by age interaction on breeding season pregnancy rate. Animals
either received 5 µg of GnRH at time of prostaglandin injection (5), 5 µg of GnRH at
prostaglandin injection and again 12 hours later (5+5), or received no exogenous GnRH
at time of prostaglandin injection (0) to serve as a control (P = 0.75).
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Figure 13. Breeding season pregnancy rates among heifers and cows (P = 0.01).
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Study 2

Expression of Estrus
Expression of estrus was not influenced by treatment (P = 0.60; Figure 14), age (P
= 0.18), or a treatment by protocol interaction (P = 0.55; Figure 15); however, it was
influenced by synchronization protocol (P < 0.0001; Figure 16). There was greater
expression of estrus among the animals synchronized with the MGA-PG (MGA) protocol
versus the 7-day CO-Synch + CIDR (CO-Synch) protocol (58 ± 1% versus 49 ± 2%,
respectively).

FTAI Conception Rates
Conception rates to FTAI were not influenced by treatment (P = 0.95; Figure 17),
age (P = 0.90), protocol (P = 0.11; Figure 18), or a treatment by protocol interaction (P =
0.89; Figure 19). A large proportion of the heifers on the MGA treatment did not have
EstroTect patches and, therefore, the effect of estrus by treatment or estrus by protocol
could not be evaluated.

Breeding Season Pregnancy Rates
Breeding season pregnancy rates were not influenced by treatment (P = 0.34;
Figure 20) or a treatment by protocol interaction (P = 0.86; Figure 22), however they
were impacted by synchronization protocol (P < 0.0001; Figure 23). Animals
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synchronized using the MGA protocol had increased overall pregnancy rates compared to
animals synchronized with the CO-Synch protocol (76 ± 1% versus 68 ± 2%,
respectively). There was a tendency for age to impact overall pregnancy (P = 0.10;
Figure 21). Heifers tended to have increased overall pregnancy rates compared to cows
(74 ± 1% versus 70 ± 2%, respectively).
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Figure 14. The percentage of animals that exhibited estrus by the time of fixed-time
artificial insemination in the two treatment groups. Animals either received 5 µg of
GnRH at time of prostaglandin injection (5) or received no exogenous GnRH at time of
prostaglandin injection (0) to serve as a control (P = 0.60).
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Figure 15. Treatment by protocol interaction on expression of estrus. Animals either
received 5 µg of GnRH at time of prostaglandin injection (5) or received no exogenous
GnRH at time of prostaglandin injection (0) to serve as a control (P = 0.55).
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Figure 16. The percentage of animals that exhibited estrus by the time of fixed-time
artificial insemination that were synchronized with either the MGA-PG or 7 day COSynch + CIDR protocol (P < 0.0001).
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Figure 17. Fixed-time artificial insemination conception rates among the two treatment
groups. Animals either received 5 µg of GnRH at time of prostaglandin injection (5) or
received no exogenous GnRH at time of prostaglandin injection (0) to serve as a control
(P = 0.95).
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Figure 18. The percentage of animals that conceived to fixed-time artificial insemination
synchronized with either the MGA-PG or 7 day CO-Synch + CIDR protocol (P = 0.11).
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Figure 19. Treatment by synchronization protocol interaction on fixed-time artificial
insemination conception rates. Animals either received 5 µg of GnRH at time of
prostaglandin injection (5) or received no exogenous GnRH at time of prostaglandin
injection (0) to serve as a control. Animals were synchronized using the MGA-PG or 7
day CO-Synch + CIDR protocol (P = 0.89).
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Figure 20. Breeding season pregnancy rates among animals in the two treatment groups.
Animals either received 5 µg of GnRH at time of prostaglandin injection (5) or received
no exogenous GnRH at time of prostaglandin injection (0) to serve as a control (P =
0.34).
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Figure 21. Breeding season pregnancy rates among heifers and cows (P = 0.10).
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Figure 22. Treatment by synchronization protocol interaction on overall pregnancy rates.
Animals either received 5 µg of GnRH at time of prostaglandin injection (5) or received
no exogenous GnRH at time of prostaglandin injection (0) to serve as a control. Animals
were synchronized using the MGA-PG or 7 day CO-Synch + CIDR protocol (P = 0.86).
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Figure 23. Breeding season pregnancy rates of animals previously synchronized with the
MGA-PG fixed-time artificial insemination (FTAI) and 7-day CO-Synch + CIDR FTAI
protocol (P < 0.0001).
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DISCUSSION

Increased circulatory estradiol is the primary signal for an animal to initiate
standing estrus and initiate the process of ovulation (Allrich, 1994; Perry and Perry,
2008). This has been evidenced by an observed 27% increase in conception rate among
animals that exhibited estrus by the time of FTAI in a meta-analysis utilizing over 10,000
animals across various synchronization protocols (Richardson et al., 2016). Estradiol
also plays an important role in setting up the uterine environment to sustain the early
embryo (Bauersachs et al., 2005). Therefore, investigation into ways to increase
circulatory estradiol and expression of estrus has been the focus of many research
endeavors.
Increased estradiol is stimulated by increased LH pulsatility via the two-cell twogonadotropin model (Falck, 1959; Erickson, 1978; Fortune and Quirk, 1988; Fortune et
al., 2001). McLeod et al. (1984), by administering small doses of GnRH systemically in
two-hour intervals were able to determine doses as small as 2.5 or 5 µg stimulated a
physiological pulse of LH in prepubertal cattle. Next, Ginther and Beg (2012) treated
heifers with a single 5 µg dose daily and confirmed the small physiological dose
stimulated an LH pulse following luteolysis that produced the same effects on
progesterone and estradiol as a natural LH pulse. Beef cows injected with GnRH (5 µg)
intramuscularly every 8 hours from the time of prostaglandin injection (hour 0) to 33
hours after, had elevated estradiol concentrations at hours 7, 8, and 16 (Larimore et al.,
2016). A single small dose of GnRH (5 µg or 10 µg) at time of CIDR
removal/prostaglandin injection using a 7-day CO-Synch + CIDR protocol, shortened the
interval to estrus among heifers and increased expression of estrus (Rich et al., 2018a).
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Additionally, supplementation with small doses of GnRH (5 µg) at CIDR
removal/prostaglandin injection and again 12 hours later (5+5 µg), did not impact
circulating concentrations of estradiol or expression of estrus, but the 5+5 µg treatment
did increase conception rates to FTAI compared to both the 10 µg dose and control
animals (Rich et al., 2018b).
To endorse the addition of a supplemental dose of GnRH to a synchronization
protocol the treatment must not negatively impact expression of estrus or pregnancy
rates, and it must work similarly across various herds with differing management
strategies and animal statuses. In reference to expression of estrus, treatment or a
treatment by protocol interaction did not impact expression of estrus in either study (1 or
2). Expression of estrus was impacted by age in study 1 but not study 2. In study 1,
cows had increased expression of estrus compared to heifers. In study 2, expression of
estrus was influenced by synchronization protocol. There was increased estrus
expression among animals synchronized with the MGA protocol compared to the COSynch protocol.
In study 1, the interaction of treatment by age tended to influence FTAI
conception rates (P = 0.07), specifically cows treated with a single dose of 5 µg at
prostaglandin injection had increased FTAI conception rates, but breeding season
pregnancy rates were similar. Expression of estrogen receptor alpha was increased in
cultured luteal phase bovine endometrium treated with GnRH, suggesting a role in
endometrial responsiveness to estradiol and associated uterine receptivity and
maintenance of pregnancy (Singh et al., 2009). Additionally, cleavage rates were
increased among bovine oocytes cultured with GnRH agonists (Funston and Seidel,
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1995). Therefore, the observation of increased FTAI conception rates with no differences
in expression of estrus could be indicative of the supplemental dose of GnRH impacting
these further downstream mechanisms. In study 2, however, treatment did not impact
FTAI conception rates, or overall breeding season pregnancy rates but this could be due
to the number of cows being greatly reduced in comparison to heifers in Study 2.
Breeding season pregnancy rates were not impacted by treatment or a treatment
by age or protocol interaction in either study (1 or 2). Age tended to or did influence
breeding season pregnancy rates. In study 1, cows had increased pregnancy rates
compared to heifers, this could be the drawn out effects of FTAI conception rates where
heifers that had reduced FTAI conception rates were not able to make up the difference in
conception rates across the entire breeding season. In study 2, heifers tended to have
increased breeding season pregnancy rates compared to cows, this could be explained by
the natural physiological differences among heifers and cows. Cows are required to raise
their existing calf by producing milk while trying to reinitiate cyclicity and support a new
pregnancy, and reproductive traits are lower in priority ranking to maintenance and
lactation in the nutrient partitioning hierarchy (Short and Adams, 1988). In study 2, there
was also an observed effect of synchronization protocol on breeding season pregnancy
rates, where animals synchronized using the MGA protocol had increased breeding
season pregnancy rates compared to animals synchronized using the CO-Synch protocol.
The use of MGA is labeled only for heifers; therefore, the observed difference here could
partly be explained by a similar difference in nutrient utilization and partitioning, where
heifers do not have the same requirements of lactation and raising a calf that cows do.
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Another potential reason for this observed difference in protocol pregnancy rates
could be due to duration of progestin treatment. Decreases in fertility associated with
short-term (≤ 9 days) progestin treatments have been hypothesized to occur via persistent
dominant follicles; where follicles that had prolonged dominance (10 or 12 days)
produced reduced pregnancy rates (Beal et al., 1988; Patterson et al., 1989; Sirois and
Fortune, 1990; Stock and Fortune, 1993). Therefore, there could have been some
persistent follicles present among the 7 day CO-Synch + CIDR protocol heifers, while
the heifers synchronized using the MGA-PG protocol are fixed-time artificially
inseminated off of the subsequent ovulation negating the potential for persistent follicles.
In summary, in study 1 a treatment by age interaction tended to increase FTAI
pregnancy rates among cows treated with 5 µg of GnRH at prostaglandin injection,
however treatment with GnRH did not impact estrus or breeding season pregnancy rates.
Furthermore, in study 2 treatment did not impact expression of estrus, FTAI conception
rates, or breeding season pregnancy rates.
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CHAPTER 3
DIFFERENCES IN RELATIVE ABUNDANCE OF GnRH-I, GnRH-II, AND GnRH-IR
IN GRANULOSA CELLS OF BOVINE ANTRAL FOLLICLES AT SPECIFIC
STAGES OF FOLLICULAR DEVELOPMENT
ABSTRACT
A previous study reported that bovine follicles with greater follicular fluid
concentrations of estradiol had decreased expression of GnRH-I and GnRH-II in
granulosa cells (GC). The objective of this study was to characterize relative abundance
of GnRH-I, GnRH-II, and GnRH-IR mRNA within GC of follicles at specific stages of
development. Beef cows were synchronized, and ovaries were collected at specific
stages of follicular development [pre-selection (PRE), post-selection (POST), and postselection 24 h after luteal regression (POST-PG)]. All surface follicles were classified as
small (< 5 mm), medium (5-8 mm), or large (> 8 mm) and aspirated to collect GC. Large
follicles from each animal were kept separate and all other follicles were pooled by size
within animal (n = 27, 27, and 18 for small, medium, and large). Total cellular RNA was
extracted, and RT-PCR was performed for GnRH-I, GnRH-II, GnRH-IR, and GAPDH.
Data were analyzed using the MIXED procedure of SAS. Across all follicles, GnRH-I
and GnRH-II were not influenced by stage (P = 0.49) but were influenced by size (P <
0.0001). Smalls (4.55 ± 0.39 and 3.91 ± 0.44, respectively) had greater expression (P ≤
0.01) compared to mediums (0.83 ± 0.39 and 1.41 ± 0.44, respectively) and larges (0.52 ±
0.47 and 2.12 ± 0.54, respectively). There was also a stage by size interaction for GnRHI, GnRH-II, and GnRH-IR (P ≤ 0.03). POST and POST-PG smalls had increased (P ≤
0.03) expression of GnRH-II and GnRH-IR mRNA compared to PRE smalls. POST
smalls had (P = 0.02) increased expression of GnRH-I mRNA compared to PRE smalls.
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PRE mediums had increased GnRH-I and GnRH-II mRNA expression (P ≤ 0.03)
compared to POST-PG mediums. When only the largest follicle for each animal was
evaluated, stage of development influenced expression of GnRH-I (P = 0.03) but not
GnRH-II (P = 0.91) or GnRH-IR (P = 0.16). For GnRH-I, PRE tended ( 2.28 ± 0.55; P =
0.09) to have increased expression compared to POST (0.92 ± 0.55) and did have greater
expression compared to POST-PG ( 0.11 ± 0.55; P = 0.01), and POST-PG follicles had
increased follicular fluid estradiol-17β concentrations (P < 0.0001) compared to PRE and
POST follicles. Thus, GnRH within antral follicles may be a key regulator of the
follicle’s ability to produce estradiol. Supported by AFRI Grant No. 2018-67016-27578
from USDA. USDA is an equal opportunity provider and employer.

INTRODUCTION

Gonadotropin releasing hormone has been reported to have both stimulatory and
inhibitory actions on steroidogenesis in the ovary (Sharpe, 1982). Gonadotropin
releasing hormone in the ovary was first characterized in rats (Clayton et al., 1979).
More recently, GnRH-IR mRNA abundance has been characterized in bovine granulosa
cells and luteal tissue (Ramakrishnappa et al., 2001). In this study, small antral follicles
had increased GnRH-IR mRNA relative abundance compared to medium and large antral
follicles.
Additionally, a study by our lab reported that bovine follicles with greater
follicular fluid concentrations of estradiol had decreased relative expression of GnRH-I
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and GnRH-II in granulosa cells (GC) (Rich, 2017). Relative abundance of GnRH-I and
GnRH-II mRNA in bovine GC was increased in follicles with decreased estradiol
concentrations, and in some follicles with increased concentrations of estradiol which we
speculate to have been undergoing atresia. Thus, the decreased abundance of GnRH-I
and GnRH-II in large follicles and those with elevated concentrations of estradiol may
indicate that GnRH is capable of regulating estradiol production in bovine antral follicles
(Rich, 2017).
Interestingly, there are reports of GnRH-II inactivation in some mammalian
species. The GnRH-II gene is silenced in the mouse, leaving only the gene encoding
GnRH-I (Pawson et al., 2003). Furthermore, in cattle, a study revealed that the GnRH-II
peptide is functionally inactivated (Morgan et al., 2006). Additionally, in humans,
chimpanzees, horses, sheep, rodents, and cows the GnRH-IIR has been silenced and is
not full-length (Millar, 2003; Morgan et al., 2003; Pawson et al., 2003; Millar et al.,
2004; Morgan et al., 2006). Through ligand-induced-selective signaling, however,
signaling of GnRH-II can be accommodated by the GnRH-IR and has unique signaling
roles to GnRH-I (Maudsley et al., 2004; Millar et al., 2004; Millar, 2005).
Therefore, the objective of this study was to characterize relative abundance of
GnRH-I, GnRH-II, and GnRH-IR mRNA within GC of follicles at specific stages of
development. The hypothesis of the study was that GnRH-I and GnRH-II mRNA
abundance would be increased in small, less developed follicular stage follicles, and
those containing decreased concentrations of estradiol.
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MATERIALS AND METHODS

All procedures were approved by the South Dakota State University Institutional
Animal Care and Use Committee.

Experimental Design
A group of mature beef cows having normal estrous cycles were synchronized
into specific stages of follicular development. Cows were observed for estrus, then
during the midluteal period a new follicular wave was induced with an injection of GnRH
(100 μg). Transrectal ultrasonography was performed daily to determine ovulation,
initiation of a new follicular wave, and timing of selection. Follicles were collected
following initiation of a new follicular wave and prior to selection, as well as after
selection of a dominant follicle or after selection of a dominant follicle and regression of
the corpus luteum.

Follicle Classifications
Bovine antral follicles were classified by size and stage. For follicle size
classification calipers were used and follicles were classified as small (<5 mm, n = 27),
medium (5-8 mm, n = 27), or large (>8 mm, n = 18). For follicular stage ovaries were
collected following initiation of a new follicular wave, pre-selection (PRE). Ovaries
were collected following selection of a dominant follicle (POST). An injection of PGF2α
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(25 mg) following selection of a dominant follicle was administered and ovaries were
collected 48 hours later before any animal initiated standing estrus (POST-PG).

Tissue Collection
Immediately following slaughter or ovariectomy (Youngquist et al., 1995;
Alexander, 2013), all visible surface follicles were classified as small (<5 mm), medium
(5–8 mm), or large (>8 mm). Follicular fluid (FF) was aspirated from all follicles, and
GC were separated from the follicular fluid by centrifugation, placed in RNase Free tubes
(USA Scientific), and snap frozen in liquid nitrogen until radioimmunoassay was
performed to determine FF estradiol-17β and progesterone concentrations (Engel et al.,
2008; Perry and Perry, 2008). All samples were stored at -80°C. Total cellular RNA was
extracted from the GC and RT-PCR was performed to determine relative abundance of
mRNA for GnRH-I, GnRH-II, GnRH-IR, and GAPDH.

Radioimmunoassay
Follicular fluid concentrations of estradiol 17-β were determined by
radioimmunoassay (RIA) using the methods described by Perry and Perry (2008). Serial
dilutions of follicular 1:100, 1:1000, and 1:10,0000 were analyzed to determine the
concentration of estradiol in each sample. Inter- and intra-assay CV were 4.7% and
3.5%, respectively and assay sensitivity was 0.4 pg/mL. Follicular fluid concentrations
of progesterone were determined by RIA using methods described by (Engel et al., 2008).
All samples were run in a single assay and the intra-assay CV was 2.89%, and assay
sensitivity was 0.4 ng/mL. The E2/P4 ratio was calculated for each follicle size per
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follicular stage, and follicles were classified as atretic if the ratio was <1 (Rosales-Torres
et al., 2000; Hernandez-Coronado et al., 2015), and removed from further analysis (n =
1). The follicle that was removed was a medium PG follicle.

RNA extraction and Real Time RT-PCR
Total cellular RNA was extracted from granulosa cells using a Qiagen RNeasy
Plus Mini Kit (Austin, Texas) prior to RNA isolation. Pure RNA was dissolved in
nuclease free water, and a spectrophotometer (NanoDrop Technologies, Wilmington, DE)
was used to determine RNA concentration for each sample. The RNA samples were then
stored in a -80˚C freezer. The RNA was diluted to 70 ng/µl and Real Time RT-PCR was
performed in duplicate using iScript One-Step RT-PCR Kit with SYBR Green (Bio-Rad
Laboratories, Inc.) and a Stratagene MX 3000p QPCR machine. The integrity of each
sample was determined using an Agilent RNA Screen Tape System, sample RINs were
between 8.5 and 9.2. Transcript abundance of GnRH-I and GnRH-II was measured using
the primers in Table 5, and GAPDH was used as the endogenous reference gene. The
primers were diluted to a concentration of 10 µM and all products were verified for
identity by sequencing (Iowa State Genomics Core). Each plate contained negative
controls to ensure no background contamination was occurring. The PCR program
consisted of 10 minutes at 50˚C, 1 minute at 95˚C for melting, and 30 seconds at 60˚C for
annealing and elongation for 40 cycles. Base pair size of all PCR products was
confirmed through gel electrophoresis and the intra-assay CVs were 13.6%, 9.6%, and
10.8% for GnRH-I, GnRH-II, and GAPDH, respectively (Bustin et al., 2009) .
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By referencing a previously reported inactivated bovine GnRH-II gene sequence
three primer pairs were designed (Table 6). The primer pairs were designed to overlap
the reported amino acid substitution at position eight which renders the gene inactive
(Morgan et al., 2006). The authors created granulosa cells mRNA pools and performed
real time RT-PCR with the three primer pairs for bovine GnRH-II and sequenced the
transcripts.

Statistical Analysis
Differences in follicular fluid concentrations of estradiol, progesterone, relative
abundance of GnRH-I mRNA, relative abundance of GnRH-II mRNA, and relative
abundance of GnRH-IR mRNA were analyzed by analysis of variance using the PROC
MIXED of SAS (SAS Inst. Inc., Cary, NC). When the F statistic was significant (P <
0.05), mean separation was performed using least significant differences (Means ± SEM,
Snedecor and Cochran, 1989). Difference were considered significant when P ≤ 0.05 and
a tendency when P > 0.05 by P ≤ 0.10.

RESULTS

GnRH-I mRNA Abundance
Granulosa cell (GC) GnRH-I mRNA relative abundance was influenced by
follicle size (P < 0.0001; Figure 24), small follicles had increased GC GnRH-I mRNA
relative abundance (4.5502 ± 0.4353; P < 0.0001) compared to medium and large
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follicles which did not differ (0.5002 ± 0.4353 and 0.5167 ± 0.5332, respectively; P =
0.98).
Across all follicles, follicular stage influenced (P = 0.0093; Figure 25) GC
GnRH-I mRNA relative abundance, PRE follicles had decreased GC GnRH-I mRNA
relative abundance (0.8162 ± 0.5403; P = 0.0024) compared to POST follicles (3.0656 ±
0.4656). PRE and POST follicles were not different (P ≥ 0.14) compared to POST-PG
follicles (2.4261 ± 0.9183).
For the largest or synchronized follicle, follicular stage influenced (P = 0.0325;
Figure 26) GC GnRH-I mRNA relative abundance, PRE follicles had increased GC
GnRH-I mRNA relative abundance (2.2844 ± 0.5517; P = 0.01) compared to POST-PG
follicles (0.11 ± 0.5517). PRE follicles tended to have increased GC GnRH-I mRNA
relative abundance compared to POST (0.9233 ± 0.5517; P = 0.094). POST and POSTPG follicle GC GnRH-I mRNA abundance did not differ (P = 0.31). For the medium
follicles present across all stages, follicular stage influenced (P = 0.025; Figure 27) GC
GnRH-I mRNA relative abundance, PRE follicles had increased GC GnRH-I mRNA
relative abundance (2.2844 ± 0.7431; P ≤ 0.018) compared to POST and POST-PG
follicles which did not differ (-0.313 ± 0.7049 and -0.4906 ± 0.7881, respectively; P =
0.87). For the small follicles present across all stages, follicular stage tended to influence
(P = 0.073; Figure 28) GC GnRH-I mRNA relative abundance, POST follicles had
increased GC GnRH-I mRNA relative abundance (5.6006 ± 0.6984; P = 0.026) compared
to PRE follicles (3.25 ± 0.6984) and did not differ from POST-PG follicles (4.8 ± 0.6894;
P = 0.13). Granulosa cell GnRH-I mRNA abundance did not differ among POST and
POST-PG follicles (5.6006 ± 0.6984 and 4.8 ± 0.6984, respectively; P = 0.43).
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GnRH-II mRNA Abundance
Sequencing of bovine pooled granulosa cell transcripts from real time RT-PCR
with three primer pairs for bovine GnRH-II revealed that the position eight substitution
that was previously reported (Morgan et al., 2006) was also present among our samples.
Thus the GnRH-II mRNA transcripts evaluated in this study were similar to the reported
inactivated bovine GnRH-II gene (Morgan et al., 2006); however, the production of this
transcript was still regulated by changes in size and stage of follicular development.
Granulosa cell GnRH-II mRNA relative abundance was influenced by follicle size
(P = 0.0003; Figure 29), small follicles had increased GC GnRH-II mRNA relative
abundance (3.9085 ± 0.4856; P ≤ 0.023) compared to medium and large follicles which
did not differ (1.0146 ± 0.4856 and 2.1178 ± 0.5947, respectively; P = 0.16).
Across all follicles, follicular stage influenced (P = 0.0052; Figure 30) GC
GnRH-II mRNA relative abundance, POST follicles had increased GC GnRH-II mRNA
relative abundance (3.3946 ± 0.4364; P = 0.0012) compared to PRE follicles (1.1406 ±
0.5063) but did not differ from POST-PG follicles (2.5983 ± 0.8606; P = 0.41).
Granulosa cell GnRH-II mRNA abundance did not differ among PRE and POST-PG
follicles (1.1406 ± 0.5063 and 2.5983 ± 0.8606, respectively; P = 0.15).
For both the largest (P = 0.91; Figure 31) or synchronized follicle and medium (P
= 0.14; Figure 32) follicles present, follicular stage did not influence GC GnRH-II
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mRNA relative abundance. For the small follicles present across all stages, follicular
stage influenced (P = 0.015; Figure 33) GC GnRH-II mRNA relative abundance, PRE
follicles had decreased GC GnRH-II mRNA relative abundance (1.9867 ± 0.77; P ≤
0.0365) compared to both POST and POST-PG follicles which did not differ (5.34 ± 0.77
and 4.3989 ± 0.77, respectively; P = 0.396)

GnRH-IR mRNA Abundance
Granulosa cell GnRH-IR mRNA relative abundance was influenced by follicle
size (P < 0.0023; Figure 34). Medium follicles had decreased GC GnRH-IR mRNA
relative abundance (-0.614 ± 0.6913; P ≤ 0.006) compared to small and large follicles
which did not differ (2.1044 ± 0.6518 and 2.9868 ± 0.8214, respectively; P = 0.40).
Across all follicles, follicular stage did not influence (P = 0.42; Figure 35) GC
GnRH-IR mRNA relative abundance. For the largest or synchronized follicle (P = 0.162;
Figure 36), and for medium follicles (P = 0.8113; Figure 37) present follicular stage did
not influence GC GnRH-IR mRNA relative abundance. For the small follicles present
across all stages, follicular stage influenced (P < 0.0001; Figure 38) GC GnRH-IR
mRNA relative abundance, PRE follicles had decreased GnRH-IR mRNA relative
abundance (-1.1389 ± 0.666; P < 0.0001) compared to POST and POST-PG follicles
which did not differ (3.68 ± 0.666 and 3.77 ± 0.666, respectively; P = 0.923).

Follicular Fluid Estradiol Concentration
Follicular fluid estradiol concentrations were influenced by follicle size (P <
0.0001; Figure 39). Large follicles had increased estradiol (140,536 ± 32,258 pg/mL)
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compared to medium follicles (10,548 ± 7,129 pg/mL) which had similar estradiol
concentrations compared to small follicles (1,620 ± 7,099 pg/mL). Follicular stage also
influenced (P < 0.0001; Figure 40) concentrations of estradiol. Follicles in the POST-PG
group had increased concentrations of estradiol (86,588 ± 7,389 pg/mL) compared to
POST follicles (12,302 ± 7,129 pg/mL) which had similar estradiol concentrations
compared to PRE follicles (10,453 ± 2,867 pg/mL). There was also a size by follicular
stage interaction effect on follicular fluid estradiol concentrations (P < 0.0001; Figure
41). Large POST-PG follicles had greater concentrations of estradiol (252,616 ± 13,043
pg/mL; P < 0.0001) compared to all other follicle size and stage combinations.

Follicular Fluid Progesterone Concentration
There was no effect of size (P = 0.058; Figure 42) follicular stage (P = 0.13;
Figure 43) or a size by stage interaction (P = 0.725) on follicular fluid progesterone
concentrations.
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Gene

Primer

Primer Sequence

Fragment
Size

Reference

Forward 5’-GCAGCTCTGGAAAGTCTGATTG-3’
170
(Ramakrishnappa
Reverse 5’-TCCATGCAACCTGGTGTAAGAA-3’
et al., 2003)
GnRH-II Forward 5’-TCGGGGGATGATACACCACT-3’
226
(Ramakrishnappa
Reverse 5’-TTCAGCGTGCGGGTTTTCTA-3’
et al., 2003)
GnRH-IR Forward 5’-GTCCTTCATCAGGATCCCCAC-3’
281
(Ramakrishnappa
5’-CTTTCTTTGACTTTCTATGCAGTCT-3’
Reverse
et al., 2001)
GAPDH Forward 5’-GATTGTCAGCAATGCCTCCT-3’
94
(Han et al., 2006)
5’-GGTCATAAGTCCCTCCACGA-3’
Reverse
Table 5. Genes, Primer sequences, and fragment size for genes amplified during Real
Time RT-PCR.
GnRH-I

Gene

Primer

Primer Sequence

Fragment Size

Forward 5’-AAGTGCCAGTTGTCCAAGGG-3’
497
Reverse 5’-GTGGTGTATCATCCCCCGAG-3’
GnRH-IIb Forward 5’-CTGGCAAAGTCGGGAGACTG-3’
768
5’-CACAGGGGGCATCTCATCAT-3’
Reverse
GnRH-IIc Forward 5’-TCAGAGTCCAGACCCCTGTAG-3’
403
5’-ACTTGGGAGGGTATGGGCAA-3’
Reverse
Table 6. Primer pairs of the inactivated bovine GnRH-II genes that were run using Real
Time RT-PCR with bovine granulosa cell mRNA pools and sequenced.
GnRH-IIa

Relative Abundance of GnRH-I
mRNA
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Figure 24. Relative abundance of GnRH-I mRNA in granulosa cells of small (<5 mm),
medium (5-8 mm), and large (>8 mm) bovine antral follicles (P < 0.0001). abSuperscripts
differ (P < 0.05).
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Figure 25. Relative abundance of GnRH-I mRNA in granulosa cells across all bovine
antral follicles present on the ovary at a specific follicular stage (P < 0.01).
ab
Superscripts differ (P < 0.05). Animals were synchronized into one of three specific
follicular stages and ovaries were collected pre-selection (PRE), following selection of a
dominant follicle (POST), and following selection of a dominant follicle and regression
of an existing CL via PGF2α (POST-PG).
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Figure 26. Relative abundance of GnRH-I in granulosa cells of the largest/synchronized
bovine antral follicle within each follicular stage (P = 0.03). Different superscripts with
an asterisk (*) represent tendencies (P ≤ 0.10). abSuperscripts differ (P < 0.05). Animals
were synchronized into one of three specific follicular stages and ovaries were collected
pre-selection (PRE), following selection of a dominant follicle (POST), and following
selection of a dominant follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 27. Follicular stage by size interaction for medium bovine antral follicles on
relative abundance of GnRH-I mRNA (P = 0.02). abSuperscripts differ (P < 0.05).
Animals were synchronized into one of three specific follicular stages and ovaries were
collected pre-selection (PRE), following selection of a dominant follicle (POST), and
following selection of a dominant follicle and regression of an existing CL via PGF2α
(POST-PG).
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Figure 28. Follicular stage by size interaction for small bovine antral follicles on relative
abundance of GnRH-I mRNA (P = 0.07). Different superscripts with an asterisk (*)
represent tendencies (P ≤ 0.10). abSuperscripts differ (P < 0.05). Animals were
synchronized into one of three specific follicular stages and ovaries were collected preselection (PRE), following selection of a dominant follicle (POST), and following
selection of a dominant follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 29. Relative abundance of GnRH-II mRNA in granulosa cells of small (<5 mm),
medium (5-8 mm), and large (>8 mm) bovine antral follicles (P < 0.01). abSuperscripts
differ (P < 0.05).
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Figure 30. Relative abundance of GnRH-II mRNA in granulosa cells across all bovine
antral follicles present at a specific follicular stage (P < 0.01). abSuperscripts differ (P <
0.05). Animals were synchronized into one of three specific follicular stages and ovaries
were collected pre-selection (PRE), following selection of a dominant follicle (POST),
and following selection of a dominant follicle and regression of an existing CL via
PGF2α (POST-PG).
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Figure 31. Relative abundance of GnRH-II mRNA in granulosa cells of the
largest/synchronized bovine antral follicle within each follicular stage (P = 0.91).
Animals were synchronized into one of three specific follicular stages and ovaries were
collected pre-selection (PRE), following selection of a dominant follicle (POST), and
following selection of a dominant follicle and regression of an existing CL via PGF2α
(POST-PG).
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Figure 32. Follicular stage by size interaction for medium bovine antral follicles on
relative abundance of GnRH-II mRNA (P = 0.14). Animals were synchronized into one
of three specific follicular stages and ovaries were collected pre-selection (PRE),
following selection of a dominant follicle (POST), and following selection of a dominant
follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 33. Follicular stage by size interaction for small bovine antral follicles on relative
abundance of GnRH-II mRNA (P = 0.01). abSuperscripts differ (P < 0.05). Animals
were synchronized into one of three specific follicular stages and ovaries were collected
pre-selection (PRE), following selection of a dominant follicle (POST), and following
selection of a dominant follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 34. Relative abundance of GnRH-IR mRNA in granulosa cells of small (<5 mm),
medium (5-8 mm), and large (>8 mm) bovine antral follicles (P < 0.01). abSuperscripts
differ (P < 0.05).
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Figure 35. Relative abundance of GnRH-IR mRNA in granulosa across all bovine antral
follicles present at a specific follicular stage (P = 0.4157). Animals were synchronized
into one of three specific follicular stages and ovaries were collected pre-selection (PRE),
following selection of a dominant follicle (POST), and following selection of a dominant
follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 36. Relative abundance of GnRH-IR mRNA in granulosa cells of the
largest/synchronized bovine antral follicle within each follicular stage (P = 0.16).
Animals were synchronized into one of three specific follicular stages and ovaries were
collected pre-selection (PRE), following selection of a dominant follicle (POST), and
following selection of a dominant follicle and regression of an existing CL via PGF2α
(POST-PG).
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Figure 37. Follicular stage by size interaction for medium bovine antral follicles on
relative abundance of GnRH-IR mRNA (P = 0.81). Animals were synchronized into one
of three specific follicular stages and ovaries were collected pre-selection (PRE),
following selection of a dominant follicle (POST), and following selection of a dominant
follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 38. Follicular stage by size interaction for small bovine antral follicles on relative
abundance of GnRH-IR mRNA (P < 0.0001). abSuperscripts differ (P < 0.05). Animals
were synchronized into one of three specific follicular stages and ovaries were collected
pre-selection (PRE), following selection of a dominant follicle (POST), and following
selection of a dominant follicle and regression of an existing CL via PGF2α (POST-PG).

123

Estradiol-17β by Size
FF Concentration of Estradiol-17β,
pg/mL

200,000

a

180,000

P < 0.0001

160,000
140,000
120,000
100,000
80,000
60,000
40,000
20,000

b

b

0
Small

Medium

Large

Figure 39. Follicular fluid estradiol concentrations of small (<5 mm), medium (5-8 mm),
and large (>8 mm) bovine antral follicles (P < 0.0001). abSuperscripts differ (P < 0.05).
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Figure 40. Follicular fluid estradiol concentrations of PRE, POST, and POST-PG bovine
antral follicles (P < 0.0001). abSuperscripts differ (P < 0.05). Animals were
synchronized into one of three specific follicular stages and ovaries were collected preselection (PRE), following selection of a dominant follicle (POST), and following
selection of a dominant follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 41. Follicular stage by size interaction on follicular fluid estradiol concentrations
(P < 0.0001). abSuperscripts differ (P < 0.05). Small (< 5 mm), medium (5-8 mm), and
large (> 8 mm) bovine antral follicles collected from specific follicular stages. Animals
were synchronized into one of three specific follicular stages and ovaries were collected
pre-selection (PRE), following selection of a dominant follicle (POST), and following
selection of a dominant follicle and regression of an existing CL via PGF2α (POST-PG).
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Figure 42. Follicular fluid progesterone concentrations of small (<5 mm), medium (5-8
mm), and large (>8 mm) bovine antral follicles (P = 0.58).
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Figure 43. Follicular fluid progesterone concentrations of PRE, POST, and POST-PG
bovine antral follicles (P = 0.13). Animals were synchronized into one of three specific
follicular stages and ovaries were collected pre-selection (PRE), following selection of a
dominant follicle (POST), and following selection of a dominant follicle and regression
of an existing CL via PGF2α (POST-PG).
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DISCUSSION

A GnRH-like protein was identified in bovine follicles, and this protein
suppressed LH-stimulated accumulation of cAMP in a dose dependent manner (Aten et
al., 1987). Greatest concentrations of this GnRH-like protein were found within the
granulosa cell layer (Ireland et al., 1988). These studies, however, were unable to show
function of this GnRH-like protein. Gonadotropin releasing hormone ovarian presence;
however, has been reported in the rat, humans, pigs and cows and its actions on
steroidogenesis have been characterized as both stimulatory and inhibitory (Sharpe, 1982;
Janssens et al., 2000; Ramakrishnappa et al., 2001; Ramakrishnappa et al., 2003; Millar,
2005) with stimulatory effects at low concentrations and inhibitory effects at elevated
concentrations.
Gonadotropin releasing hormone has been reported to induce follicular atresia in
rat, pig, and human follicular cells (Hsueh et al., 1984; Piquette et al., 1991; Billig et al.,
1994; Motomura, 1998; Sridaran et al., 1998; Zhao et al., 2000). In our previous study
with slaughter house sourced ovaries, highly variable amounts of GnRH-I and II mRNA
were observed in large bovine antral follicles, but it was speculated that both healthy
follicles and follicles beginning atresia were collected (Rich, 2017). In the current study
using follicular fluid estradiol and progesterone values and their respective ratio
(Rosales-Torres et al., 2000; Hernandez-Coronado et al., 2015), atretic follicles were
identified when the E2/P4 ratio was < 1 and these follicles were removed from further
analyses.
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Large follicles characteristically produce increased concentrations of estradiol
contributing to increased expression of estrus, however, some large follicles fail to
produce elevated concentrations of estradiol (Jinks et al., 2013; Perry et al., 2014).
Similarly, when a GnRH agonist was added to cultured bovine granulosa cells at a
concentration of 200 ng/mL it had a stimulatory effect on estradiol production, however,
at concentrations of 500 ng/mL and 1000 ng/mL it had an inhibitory effect on estradiol
production (Ramakrishnappa et al., 2005). Due to the reported stimulatory and inhibitory
effects on steroidogenesis within the ovary, intra-follicular GnRH could be a contributing
factor. In the current study, small follicles had increased GnRH-I and GnRH-II mRNA
abundance compared to medium and large follicles. These results are similar to those
reported previously (Rich, 2017).
Relative abundance of GnRH-I and GnRH-II mRNA was also influenced by a
follicular stage by size interaction across all follicles where, PRE follicles had decreased
GnRH-I and GnRH-II mRNA abundance compared to POST and POST-PG follicles.
This could be explained by the fact that the small follicles present and being accounted
for in this analysis during the POST and POST-PG stages (where follicular selection and
dominance had commenced and small follicles present were being suppressed) had
increased GnRH-I mRNA abundance, which is supportive of the hypothesis that GnRH is
playing a role in suppressing follicular growth. When only the largest/synchronized
follicle per stage was analyzed, PRE follicles had increased GnRH-I mRNA abundance
compared to POST and POST-PG follicles, however there were no differences detected
among the different follicular stages for GnRH-II or GnRH-IR.
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In explaining these results, we can turn to the natural characteristics of follicular
growth, selection, and dominance where a single follicle is selected for continued growth
and develops dominance over its subordinate counterparts. Follicle selection revolves
around the future dominant follicle’s ability to produce increased concentrations of
estradiol and have an increased growth rate in an FSH environment that does not sustain
the growth of other follicles (Mihm and Austin, 2002; Ginther, 2016). The pivotal event
of follicle selection is diameter deviation, and the intrafollicular factors involved in
diameter deviation are the IGF system, estradiol, and LH-R. Specifically, concentrations
of estradiol in follicular fluid increase more dramatically in future dominant follicles than
future subordinate follicles (Beg and Ginther, 2006). In the present study and a similar
previous study (Rich, 2017), larger more advanced follicular stage follicles that also had
increased concentrations of estradiol had decreased GnRH-I and GnRH-II mRNA
abundance compared to small and medium follicles of a less advanced stage with
decreased estradiol concentrations.
Following attainment of dominant follicle status, the dominant follicle becomes
the primary inhibitor of FSH secretion via negative feedback mechanisms at the level of
the HPG axis; decreased FSH concentrations and the inhibition of transient rises in FSH
prevent the emergence of a new cohort of growing follicles (Fortune, 1994; Aerts and
Bols, 2010). A second hypothesis states that dominant follicles secrete factors that
inhibit subordinate follicles directly at the level of the ovary. Many existing studies on
the local ovarian GnRH system are descriptive in nature, further investigation into the
roles of GnRH at the level of the ovary and its involvement during these pivotal follicular
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developmental stages may lead to the determination that GnRH is another key player in
follicular growth, selection, and dominance.
In a study investigating the fates of the three largest follicles of a follicular wave,
increased estradiol concentrations were detected in the future dominant follicle just
before deviation and free IGF-I in the future dominant follicle remained constant but was
decreased in future subordinate follicles (Beg et al., 2002). These observations, again,
mirror those observed in the present study, where the large more advanced follicular
stage follicles had increased estradiol concentrations, these are the follicles that also have
decreased GnRH-I and GnRH-II mRNA abundance. This logically leads to the question,
“What is the role of ovarian GnRH in this process?”
Interestingly, in the present study when the stage by size data were represented
individually, i.e. follicular stage across the largest follicle, medium follicles, or small
follicles, there are observed differences in the relative abundance of GnRH-I and GnRHII mRNA abundance. As follicles are selected and gain dominance they suppress
subordinate follicles more and more. In the present study, small follicles present at the
POST and POST-PG stages had increased GnRH-I and GnRH-II mRNA compared to
those present at the PRE stage. Additionally, when only the small follicles were analyzed
across the different follicular stages for GnRH-IR mRNA abundance, small PRE follicles
had decreased GnRH-IR compared to small follicles present at the POST and POST-PG
follicular stages. This observation could be indicative of the GnRH system playing a
significant role in follicular development by inhibiting follicle development of these
small/subordinate follicles during the POST and POST-PG stages.
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When only medium follicles were analyzed, PRE follicles had increased relative
abundance of GnRH-I mRNA compared to the medium follicles present at the POST and
POST-PG stages. However, in the present study when looking at the effect of follicle
size on relative GnRH-IR mRNA abundance, medium follicles had decreased relative
abundance compared to small and large follicles. These results taken together point to
the possibility of these follicles being able to overcome the speculated inhibitory effects
of increased GnRH-I mRNA abundance due to attenuation of receptor affinity.
In cattle, the GnRH-II gene has been reported to be inactivated, due to an amino
acid substitution within the peptide (Morgan et al., 2006). By performing real time RTPCR on bovine granulosa cell mRNA pools with primers that were designed based on
reported sequences for the inactivated GnRH-II gene (Morgan et al., 2006), the authors
were able to confirm the same amino acid substitution. However, in this study and many
other reports on the GnRH-II gene in mammals where its action is believed to be
silenced, there are differences in expression among treatments and/or stages which might
argue against a complete lack of function (Faurholm et al., 2001; Millar, 2003; Pawson et
al., 2003; Morgan et al., 2006).
In conclusion, GnRH-I, GnRH-II, and the GnRH-IR mRNA abundance were
investigated in bovine granulosa cells harvested from follicles of differing stages of
development. The relative abundance of GnRH-I and GnRH-II mRNA was increased in
small and early developmental stages of follicular development compared to large and
more advanced stage follicular development follicles, and the characteristics of these
differences in many ways are similar to those surrounding natural growth, selection, and
dominance.
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CHAPTER 4
IMMUNOHISTOCHEMICAL CHARACTERIZATION OF FACTORS KNOWN TO
REGULATE HYPOTHALAMIC GnRH IN BOVINE OVARIAN TISSUE

ABSTRACT

There is limited information on the functional role of GnRH-I at the level of the
ovary or any factors involved in its regulation. However, a considerable amount of
information exists regarding hypothalamic control of GnRH-I. Some factors at the level
of the hypothalamus that have been reported to be in opposition with or regulate GnRH
and GnRH neurons are POMC and its derivatives (i.e. α-MSH), NPY, AMH, and GnRH
itself. The objective of this study was to identify and characterize the localization of
GnRH and factors that are known to regulate GnRH production at the level of the
hypothalamus within the bovine ovary. A group of mature beef cows having normal
estrous cycles were synchronized into specific stages of follicular development, ovarian
follicular stage was confirmed via daily transrectal ultrasonography and ovaries were
collected by ovariectomy. Bovine antral follicles were classified by size and stage. For
follicular size, surface antral follicles were measures using calipers and called small (<5
mm, n = 27), medium (5-8 mm, n = 27), or large (>8 mm, n = 18). For follicular stage
ovaries were collected following initiation of a new follicular wave, pre-selection (PRE).
Ovaries were collected following selection of a dominant follicle (POST). The third
follicular stage group was given an injection of PGF2α (25 mg) following selection of a
dominant follicle was administered and ovaries were collected 48 hours later before any
animal initiated standing estrus (POST-PG). Ovarian cortex was collected and frozen
into OCT mold for immunohistochemical analysis against GnRH, α-MSH, NPY, and
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AMH. Co-localization of immunofluorescence for GnRH and these factors was present
in the granulosa cell layer(s) and plasma membrane of primordial, primary, secondary,
and small antral follicles. Immunofluorescence for AMH was detected in the granulosa
cells of growing follicles. For GnRH, α-MSH, and NPY immunofluorescence was
detected in nerve fibers surrounding the tunica adventitia of arteries, and for α-MSH in
arteriole walls within the stroma. Furthermore, NPY immunofluorescence was detected
in nerve fibers of the ovarian stroma surrounding follicles. In conclusion, the
colocalization of GnRH with factors that have been reported to regulate GnRH at the
level of the hypothalamus in the bovine ovary is suggestive of a local ovarian role of
these factors.
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INTRODUCTION

Gonadotropin releasing hormone-I is a critical controller of the hypothalamopituitary-gonadal (HPG) axis. Proper functioning of the HPG axis is crucial for
successful reproduction. Gonadotropin releasing hormone classically stimulates
gonadotropin synthesis and secretion from gonadotrope cells of the anterior pituitary,
however, there are many reports of extra-pituitary actions of GnRH (Millar, 2005;
Ramakrishnappa et al., 2005). For female reproductive physiology, one important site of
GnRH action is the ovary. Gonadotropin releasing hormone-I and GnRH-IR mRNA
abundance have been reported in bovine granulosa cells, specifically, GnRH-I and
GnRH-IR mRNA relative abundance was greater in small follicles compared to medium
and large follicles (Ramakrishnappa et al., 2001; Rich, 2017). There is limited
information on the functional role of GnRH-I at the level of the ovary or any factors
involved in its regulation. However, a considerable amount of information exists
regarding hypothalamic control of GnRH-I. Some factors at the level of the
hypothalamus that have been reported to be in opposition with or regulate GnRH and
GnRH neurons are pro-opiomelanocortin (POMC) and its derivatives (i.e. α-MSH), as
well as neuropeptide-Y (NPY), anti-Müllerian hormone (AMH), and GnRH itself.
Pro-opiomelanocortin (POMC) neurons have been reported to have direct
synapses with GnRH neurons in rats (Cheung et al., 1995; Leranth et al., 1998). Proopiomelanocortin is post-translationally cleaved into several products such as α-MSH,
ACTH, and β-endorphin (Pritchard et al., 2002). Some of these derivatives, like α-MSH,
have been reported to have excitatory effects on GnRH neurons at the level of the
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hypothalamus in mice and sheep (Backholer et al., 2009; Roa et al., 2012). Another
factor at the level of the hypothalamus that regulates GnRH is NPY. Approximately 50%
of NPY axons apposed GnRH neurons (O’Donohue et al., 1985; Turi et al., 2003; Alves
et al., 2015). Neuropeptide Y was reported to have inhibitory actions on hypothalamic
GnRH release in beef cows (Gazal et al., 1998). In various studies,
intracerebroventricular injections of NPY suppressed GnRH release, caused decreased
concentrations of LH and complete cessation of LH pulses, and decreased pulse
frequency and amplitude of GnRH (Barker-Gibb et al., 1995; Gazal et al., 1998; Thomas
et al., 1999; Estrada et al., 2003; Morrison et al., 2003). However, heifers that gained at
an accelerated rate had reduced overall NPY expression (Alves et al., 2015). AntiMüllerian hormone is another factor that may regulate GnRH, even though it is best
known for its role in the regression of müllerian ducts (Jost, 1953). In reference to
female reproductive physiology, AMH is a measure of ovarian reserve parameters (van
Rooji et al., 2002). Extragonadal presence of AMH and its receptor has been
characterized in mice, rats, humans and cattle (Bedecarrats et al., 2003; Cimino et al.,
2016; Garrel et al., 2019; Kereilwe and Kadokawa, 2020). Specifically, in mice and
humans a subset of GnRH neurons expressed the AMH receptors, and AMH strongly
activated GnRH neuron firing. AMH has been reported to increase GnRH-dependent LH
pulsatility and secretion, supportive of a central action of AMH on GnRH neurons
(Cimino et al., 2016). More recently, using RT-PCR and western blot analysis in brain
tissues of post-pubertal heifers AMH and AMH-R mRNA and protein were detected in
the POA, ARC, and ME of the hypothalamus where GnRH neurons are located (Clarke et
al., 1987; Kereilwe and Kadokawa, 2020).
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Therefore, the objective of this study was to identify factors in the bovine ovary
that regulate GnRH locally. We hypothesized that factors that exist at the level of the
hypothalamus to influence neuronal GnRH production and secretion, like NPY, α-MSH,
and AMH would be present in the bovine ovary.

MATERIALS AND METHODS

All procedures were approved by the South Dakota State University Institutional
Animal Care and Use Committee.

Experimental Design
A group of mature beef cows having normal estrous cycles were synchronized
into specific stages of follicular development. Cows were observed for estrus, then
during the midluteal period a new follicular wave was induced with an injection of GnRH
(100 μg). Transrectal ultrasonography was performed daily to determine ovulation and
initiation of a new follicular wave.

Tissue Collection
Immediately following slaughter or ovariectomy (Youngquist et al., 1995;
Alexander, 2013), all visible surface follicles were classified as small (<5 mm), medium
(5–8 mm), or large (>8 mm). Follicular fluid was aspirated from all follicles, and GC
were separated from the follicular fluid by centrifugation, placed in RNase Free tubes
(USA Scientific), and snap frozen in liquid nitrogen. Following follicle aspiration, a
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representative sample of ovarian cortex containing small and large follicles were cut and
frozen in OCT molds. All samples were stored at -80°C.

Follicle Classifications
Bovine antral follicles were classified by size and stage. Small (<5 mm, n = 27),
medium (5-8 mm, n = 27), and large (>8 mm, n = 18). For follicular stage ovaries were
collected following initiation of a new follicular wave, pre-selection (PRE). Ovaries
were collected following selection of a dominant follicle (POST). An injection of PGF2α
(25 mg) following selection of a dominant follicle was administered and ovaries were
collected 48 hours later before any animal initiated standing estrus (POST-PG).

Cryosectioning
Samples were removed from the -80°C and placed in the Leica cryotome that was
set at -20°C at least 30 minutes prior to Cryosectioning. The sample frozen in the OCT
mold was mounted on to a chuck and the Leica was set to an angle of 4 degrees, with the
dial set to section at 20 µm width, the excess OCT was sectioned off. Sections of ovarian
cortex were taken at 7 µm thickness and mounted on super frost slides, allowed to dry at
room temperature (~1 min), and then stored in slide boxes on dry ice until moved to the 80°C for storage until IHC was performed.

139
Immunohistochemistry
GnRH
Sections that had been previously mounted on slides and kept in the -80°C for storage
were fixed using 4% Paraformaldehyde for 15 minutes at 4°C similar to methods
described by (Skobowiat et al., 2013; Komatsu and Masubuchi, 2018). Sections were
then washed (all washing steps completed in 0.1 M phosphate buffered saline (PBS) four
times for 5 minutes per wash). Antigen retrieval was accomplished by incubating slides
in sodium citrate (pH 6) in a water bath at 95°C for 18 minutes, samples were then
allowed to cool to room temperature for 20 minutes before the next washing step.
Following antigen retrieval and a washing step samples were incubated in a solution of
PBS containing 0.4% PBS + 0.4% Triton-X100 (PBSTX) and 4% normal goat serum
(NSG) for at least 1 hour. The sections were then incubated in a solution containing
mouse anti-GnRH (GnRH Covance 149214; 1:1000) in PBSTX and 4% NGS for 40
hours. After incubation with the primary antibody, sections were washed and then
incubated in a solution containing Alexa Fluorophore 488 goat anti-mouse IgG (1:200;
Invitrogen), PBSTX, and 4% NGS for 1 hour. The sections were washed and dried at
37°C. Slides were covered with glass slips using prolong diamond.

NPY
Sections that had been previously mounted on slides and kept in the -80°C for
storage were fixed using 4% Paraformaldehyde for 15 minutes at 4°C similar to methods
described by (Skobowiat et al., 2013; Komatsu and Masubuchi, 2018). Sections were
then washed (all washing steps completed in 0.1 M phosphate buffered saline (PBS) four
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times for 5 minutes per wash). Sections were then incubated in a solution of PBS
containing 0.4% PBS + 0.4% Triton-X100 (PBSTX) and 4% normal goat serum (NSG) for
at least 1 hour. The sections were then incubated in a solution containing rabbit antiNPY (SIGMA N9528; 1:1000) in PBSTX and 4% NGS for 40 hours. After incubation
with the primary antibody, sections were washed and then incubated in a solution
containing Alexa Fluorophore 488 goat anti-rabbit IgG (1:200; Invitrogen), PBSTX, and
4% NGS for 1 hour. The sections were washed and dried at 37°C. Slides were covered
with glass slips using prolong diamond.

α-MSH
Sections that had been previously mounted on slides and kept in the -80°C for
storage were fixed using 4% Paraformaldehyde for 15 minutes at 4°C similar to methods
described by (Skobowiat et al., 2013; Komatsu and Masubuchi, 2018). Sections were
then washed (all washing steps completed in 0.1 M phosphate buffered saline (PBS) four
times for 5 minutes per wash). Sections were then incubated in a solution of PBS
containing 0.4% PBS + 0.4% Triton-X100 (PBSTX) and 4% normal goat serum (NSG) for
at least 1 hour. The sections were then incubated in a solution containing guinea-pig antiα-MSH (1:5000) in PBSTX and 4% NGS for 40 hours. After incubation with the
primary antibody, sections were washed and then incubated in a solution containing
Alexa Fluorophore 488 goat anti-guinea-pig IgG (1:200; Invitrogen), PBSTX, and 4%
NGS for 1 hour. The sections were washed and dried at 37°C. Slides were covered with
glass slips using prolong diamond.
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AMH
Sections that had been previously mounted on slides and kept in the -80°C for
storage were fixed using 4% Paraformaldehyde for 15 minutes at 4°C similar to methods
described by (Skobowiat et al., 2013; Komatsu and Masubuchi, 2018). Sections were
then washed (all washing steps completed in 0.1 M phosphate buffered saline (PBS) four
times for 5 minutes per wash). Antigen retrieval was accomplished by incubating slides
in sodium citrate (pH 6) in a water bath at 95°C for 18 minutes, samples were then
allowed to cool to room temperature for 20 minutes before the next washing step.
Following antigen retrieval and a washing step samples were incubated in a solution of
PBS containing 0.4% PBS + 0.4% Triton-X100 (PBSTX) and 4% normal goat serum
(NSG) for at least 1 hour. The sections were then incubated in a solution containing
mouse anti-AMH (Abcam ab24542; 1:1000) in PBSTX and 4% NGS for 40 hours. After
incubation with the primary antibody, sections were washed and then incubated in a
solution containing Alexa Fluorophore 488 goat-anti-mouse IgG (1:200; Invitrogen),
PBSTX, and 4% NGS for 1 hour. The sections were washed and dried at 37°C. Slides
were covered with glass slips using prolong diamond.

RESULTS

Ovarian Immunolocalization of GnRH
To examine the hypothesis that GnRH is produced within the bovine ovary and is
controlled in an autocrine/paracrine manner, immunohistochemistry was performed using
GnRH specific antibodies (Alves et al., 2011). Immunostaining for GnRH was present in
all follicular stages (PRE, POST, and POST-PG) examined and no differences between
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the different stages were observed. In figure 44_1 immunostaining of the granulosa cell
layer and plasma membrane of primordial follicles is shown in images (A-E), image F
shows a group of primordial follicles with a single primary follicle. The primordial
follicles display stronger immunofluorescence compared to the primary follicle. Figure
44_2 shows a primordial follicle next to an aspirated tertiary follicle that has little to no
immunofluorescence.
Figure 44_3 (A) shows small antral follicles with some weak
immunofluorescence within the granulosa cell layer. There are many examples of
differences in the immunofluorescence between different follicle types, specifically
among the granulosa layers there is increased immunofluorescence in primordial and
primary follicles and less in secondary type 4 follicles (Figures 44_4 and 44_5).
However, among antral follicles some follicular cell immunofluorescence for GnRH was
detected (Figure 44_6). Interestingly, strong GnRH immunostaining was observed in the
ovarian stroma and surrounding blood vessels throughout the cortex of solely POST and
POST-PG follicles (Figure 44_7).

143

GnRH

Granulosa cells

Primordial and primary
follicles (Figures 44_1,
44_2, 44_3, 44_4, 44_5)
Follicular cells of an antral
follicles (Figure 44_6)
x

Oocyte

Theca cells

Strong staining
(Figure 44_6)

Stroma

Ovarian Localization (Present Study)

X

Table 7. Ovarian immunolocalization of GnRH in the present study.

x

Nerve
Fibers

Strong
staining
(Figure
44_7)

Vessels

n/a

Corpus Luteum

Arterioles

x
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Ovarian Immunolocalization of α-MSH
To examine the notion that α-MSH, a factor that has been reported to stimulate
the HPG axis by exciting GnRH neurons at the level of the hypothalamus, is produced
within the bovine ovary to potentially regulate ovarian GnRH, immunohistochemistry
was performed using α-MSH specific antibodies (Cardoso et al., 2015). Immunostaining
for α-MSH was present in all follicular stages (PRE, POST, and POST-PG) examined
and no differences between the different stages were observed. Immunostaining for αMSH was detected in primordial and primary follicles and was present in granulosa cells
and the plasma membrane (Figures 45_3 and 45_6). Among tertiary follicles, there
appeared to be edge staining within the basement membrane and granulosa cells of the
antrum (Figure 45_7).
Like what was observed for GnRH, there was distinct staining within the ovarian
stroma and surrounding blood vessels for α-MSH present among all the follicular stages
(Figure 45_2). Interestingly, there were distinct areas of immunofluorescence in the
cortex of PRE ovaries (Figure 45_4). Additionally, immunostaining of α-MSH was
detected on the edges of ovarian arterioles (Figure 45_1).
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α-MSH

Granulosa cells

Primordial and
primary follicles
(Figures 45_3, 45_6)
Tertiary Follicles
(Figure 45_7)
x

Theca cells

Stroma

x

Nerve
Fibers

Strong
staining
(45_2)

Vessels

Ovarian Localization (Present Study)
Oocyte

x

Strong
staining
(Figure
45_2)

Table 8. Ovarian immunolocalization of α-MSH in the present study.

Corpus
Luteum

n/a

Arterioles

Strong
arteriole
wall
staining
(Figure
45_1)
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Ovarian Immunolocalization of NPY
To examine the notion that NPY, a factor that has been reported to decrease
hypothalamic GnRH pulse frequency and amplitude in cattle, is produced within the
bovine ovary to potentially regulate ovarian GnRH, immunohistochemistry was
performed using NPY specific antibodies (Cardoso et al., 2014; Alves et al., 2015).
Immunostaining for NPY was present in all follicular stages (PRE, POST, and POST-PG)
examined and no differences between the different stages were observed. Distinct and
specific staining for NPY was observed in nerve fibers surrounding primordial and
primary follicles (Figure 46 A & B). Nerve fiber immunoreactivity was also detected
among the theca layer of secondary (Figure 46 C & E). Immunoreactivity for NPY was
also detected in the tunica adventitia of arteries in the ovarian medulla (Figure 46 D).
Immunostaining for NPY was observed among follicular cells of some follicles as
well. Within the granulosa cell layers of a secondary type 3 follicles distinct areas of
immunofluorescence were observed (Figure 46 F). Additionally, similar edge staining in
what could be aspirated follicles as what was observed for α-MSH, was observed for
NPY (Figure 46 G and H).
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NPY

Granulosa
cells

Secondary
type 2 follicle
(Figure 46 F)
Antral
follicles
(Figure 46 G
and H)

Oocyte

x

Theca cells

Stroma

Strong immunofluorescence
surrounding primordial and
primary follicles (Figure 46 A
and B)
Theca layer surrounding
secondary follicles (46 C and
E)

Nerve Fibers

Ovarian Localization (Present Study)

Nerve fibers
present at this
layer (Figure
46 C and E)

Nerve fibers
surrounding
preantral follicles
(Figure 46 A, B, C,
and E)

Table 9. Ovarian immunolocalization of NPY in the present study.

x

Vessels

Corpus
Luteum

n/a

Arterioles

Tunica adventitia
of arteries in the
ovarian medulla
(Figure 46 D)
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Ovarian Immunolocalization of AMH
To examine the hypothesis that AMH, a factor that has recently been
characterized at the level of the hypothalamus in regions common with GnRH and was
reported to strongly activate GnRH neuron firing in mice, is produced within the bovine
ovary to potentially regulate ovarian GnRH, immunohistochemistry was performed using
AMH specific antibodies (Gruijters et al., 2003; Weenen et al., 2004; Kevenaar et al.,
2006; Malone et al., 2019). Immunostaining for AMH was present in all follicular stages
(PRE, POST, and POST-PG) examined and no differences between the different stages
were observed.
Immunoreactivity of AMH was detected in the granulosa cell layer of growing
follicles in the present study. Cuboidal granulosa cells of primary follicles displayed
staining for AMH (Figure 47 A, B, and C). Immunoreactivity for AMH was also
observed in preantral or secondary type 3 and 4 follicles (Figure 47 D and E). Among
small antral follicles there was immunofluorescence for AMH within the granulosa cell
layers (Figure 47 F and G).
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AMH

Granulosa cells

Primary, Secondary type 3
and type 4, Small antral
follicles (Figure 47)

Theca cells

X

x

Stroma

x

Nerve
Fibers

x

Vessels

n/a

Corpus
Luteum

x

Arterioles

Ovarian Localization (Present Study)
Oocyte

x

Table 10. Ovarian immunolocalization of AMH in the present study.

150
GnRH IHC Pictures

Figure 44_1. Bovine ovarian sections immunolabeled (green) with antibodies against
GnRH. (A-E) immunostaining within the granulosa cell layer and plasma membrane of
primordial follicles. (F) grouping of primordial follicles with a single primary follicle.
(A) Cortex POST, (B) Large POST, (C) Cortex POST, (D) Cortex POST-PG, (E) Large
POST, (F) Small POST-PG.
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Figure 44_2. Bovine ovarian section of a primordial follicle immunolabeled (green) with
antibodies against GnRH and an antral follicle with no immunoreactivity. Cortex POSTPG.
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Figure 44_3. Bovine ovarian sections containing small antral follicles immunolabeled
(green) with antibodies against GnRH. (A) Cortex POST (B) Small POST-PG.
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Figure 44_4. Bovine ovarian sections containing primordial and primary follicles
immunolabeled (green) within the granulosa cell layer with antibodies against GnRH.
(A) Cortex PRE, (B) Large POST-PG, (C) Small POST-PG, (D) Large POST, (E) Large
POST, (F) Small POST-PG.
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Figure 44_5. Bovine ovarian section portraying a cluster of different sized follicles
immunolabeled (green) with antibodies against GnRH. Large POST-PG.
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Figure 44_6. Bovine ovarian section of an antral follicle immunolabeled (green) with
antibodies against GnRH. Large POST.
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Figure 44_7. Bovine ovarian sections displaying immunofluorescence for GnRH (green)
within the stroma and tunica adventitia of arteries. All large POST-PG, similar
immunofluorescence was observed in, Cortex POST, and Small POST-PG.
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α-MSH IHC Pictures

Figure 45_1. Bovine ovarian section of arteriole walls immunolabeled (green) with
antibodies against α-MSH. (A) Small POST, (B) Small POST-PG, (C) Large POST.
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Figure 45_2. Bovine ovarian sections displaying immunofluorescence for α-MSH
(green) within the stroma and tunica adventitia of arteries. (A) Cortex POST, (B) Small
POST-PG, (C) Cortex PRE, (D) Large POST-PG.
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Figure 45_3. Bovine ovarian sections of primordial and primary follicles immunolabeled
(green) with antibodies against α-MSH within the granulosa cell layer and plasma
membrane. (A) Cortex PRE, (B) Cortex POST.
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Figure 45_4. Bovine ovarian sections immunolabeled (green) with antibodies against αMSH in areas throughout the ovarian stroma of pre-selection ovaries. (A and B) Cortex
PRE.
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Figure 45_5. Bovine ovarian section of an antral follicle immunolabeled (green) with
antibodies against α-MSH. Large POST-PG.
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Figure 45_6. Bovine ovarian sections containing primary follicles immunolabeled
(green) with antibodies against α-MSH. (A) Large POST-PG, (B) Cortex POST-PG, (C)
Cortex POST.
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Figure 45_7. Antral edge staining-Bovine ovarian sections containing antral follicles
immunolabeled (green) with antibodies against α-MSH on the edge of the antrum. (A
and B) Cortex PRE.
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NPY IHC Pictures

Figure 46. Bovine ovarian section displaying immunofluorescence (green) for NPY. (A,
B, C, and E) immunostaining of nerve fibers in the stroma surrounding primordial and
primary follicles. (D) immunofluorescence of fibers surrounding the tunica adventitia of
arteries. (F, G, and H) Immunofluorescence within the antrum of small preantral and
antral follicles. (A and B) Small POST, (C, D, and E) Small POST-PG, (F) Large POSTPG, (G) Ccortex PRE, (H) Small POST.
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AMH IHC Pictures

Figure 47. Bovine ovarian sections of different type follicles immunolabeled (green)
within the granulosa cell layer with antibodies against AMH. (A, B, and C) Primary
follicles. (D and E) Type 3 and type 4 secondary follicles. (F and G) Small antral
follicles. (A and B) Cortex POST, (C) Cortex PRE, (D) Large POST-PG, (E) Small
POST-PG, (F) Cortex POST, (G) Large POST-PG.
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DISCUSSION
In the present study, GnRH, α-MSH, NPY, and AMH presence was confirmed
using specific immunohistochemistry. The immunohistochemical localization of GnRH
to growing follicles is supportive of previous granulosa cell mRNA data for GnRH-I
(Rich, 2017) and the idea that this decapeptide is present and produced in the ovary. The
ovarian presence of factors that have been reported to regulate hypothalamic GnRH is
indicative of a possible co-regulation relationship of GnRH and these factors.
Immunoreactivity of GnRH-I and GnRH-IR has been localized to granulosa cells
of preantral and antral follicles in many species. Additionally, immunoreactivity for
GnRH has also been reported in the interstitial cells and theca cells of antral follicles
(Singh et al., 2011a; Chen et al., 2019). In rock dove ovaries immunohistochemistry with
GnRH-IR revealed specific markings in the plasma membrane and the perinuclear zones
of germline cells (Olea et al., 2020). In the present study immunostaining for GnRH-I
was detected in the granulosa and plasma membrane regions of primordial follicles.
Pro-opiomelanocortin and its derivatives have been reported in the sheep ovary
(Lim et al., 1983), rat and primate ovary (Chen et al., 1986; Jin et al., 1988), human
ovarian tissue (Gallinelli et al., 1995) and porcine luteal cells (Staszkiewicz et al., 2007b).
Ovarian presence of POMC and α-MSH have been characterized during different
developmental stages. In amphioxus, α-MSH was detected in the primary oocytes of
small and large growth stages of the ovary (Fang et al., 2008). The differences in POMC
and α-MSH in various reproductive tissues and during different reproductive stages is
suggestive of a functional role within the reproductive tract of females. In figure 45_7
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there is distinct edge staining for α-MSH within tertiary follicles. Before ovarian tissue
sections were collected all antral follicles were aspirated to collect follicular fluid,
therefore, it is possible that the distinct layer of immunoreactivity observed among these
tertiary follicles is follicular fluid remnants of the follicle aspiration. Immunoreactivity
for POMC and its derivatives (ACTH and α-MSH) was observed in granulosa and theca
interna cells of vitellogenic follicles but not in primordial follicles of African lung fish
(Masini et al., 1997).
Previous reports exist that characterize NPY immunofluorescence in the ovarian
stroma of pigs (Keator et al., 2010). Owman et al. (1986) performed a histochemical
comparison of NPY nerve fibers in the human ovary, fallopian tube, and uterus and
described very similar looking structures to what Keator et al. (2010) referred to as
immunofluorescence of the ovarian stroma, only they referred to the immunofluorescence
observed in human ovaries as nerve fibers around blood vessels and in the muscular
stroma. While ovarian stroma and peri-vascular blood vessel staining was not observed
in bovine ovary sections for NPY in the current study, it was detected for GnRH and αMSH. Similar staining patterns observed among these different hypothalamic control
factors of GnRH could mean they have similar functions in controlling GnRH at the level
of the ovary as well.
Nerve fiber staining of NPY in the ovary has been previously identified in pigs,
humans, and cows (Hulshof et al., 1994; Jørgensen et al., 1996; Keator et al., 2010).
Specifically, Hulshof et al., (1994), described immunoreactivity for NPY in the tunica
adventitia of arteries in the bovine ovarian medulla. In the present study the nerve fiber
immunoreactivity surrounding the follicles in Figure 45 (D) look very similar to what
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was previously described. Additionally, in the present study nerve fibers were detected
in the stroma near and surrounding preantral follicles, and this same immunoreactivity
was previously reported in the adult bovine ovary by Hulshof et al., (1994). Specifically,
immunoreactivity was localized to arteries/arterioles of the ovary, nerve fibers in the
stroma near preantral follicles, and in the theca externa of antral follicles, however, there
were no differences in immunoreactivity in bovine ovarian tissue at different stages of the
ovarian cycle (Hulshof et al., 1994). Neuropeptide Y is well known for is
vasoconstrictive properties, therefore, its presence within the stroma and theca layers
surrounding follicles may point to a control mechanism in how much blood is delivered
to these follicles. This would in turn control how much cholesterol was delivered to these
tissues ultimately having the potential to impact steroidogenesis.
Anti-Müllerian hormone is indicative of the ovarian reserve and female
reproductive potential (van Rooij et al., 2002), it regulates folliculogenesis (Gruijters et
al., 2003; Weenen et al., 2004) by inhibiting follicular growth (Yang et al., 2017;
Barbotin et al., 2019). Like previous reports AMH immunofluorescence was detected in
the granulosa cells of growing follicles in the present study. Specifically,
immunoreactivity was detected within the granulosa cells layer of primary (Gruijters et
al., 2003; Weenen et al., 2004), secondary or small and large preantral (Gruijters et al.,
2003; Weenen et al., 2004; Kevenaar et al., 2006; Yang et al., 2017), and small antral
follicles (Gruijters et al., 2003; Weenen et al., 2004; Yang et al., 2017). At the level of
the hypothalamus, AMH activated GnRH neurons in mice (Cimino et al., 2016). The colocalization of GnRH with AMH could be corroborative of their collaboration in
regulating follicular growth.

169
In conclusion, the co-localization of GnRH with factors that have been reported to
regulate GnRH at the level of the hypothalamus in the bovine ovary is suggestive of a
local ovarian role of these factors. Further research is necessary to elucidate the exact
actions of these factors at the ovary, however, there presence in small growing follicles,
with previous reports of bovine granulosa cell GnRH mRNA abundance being increased
in follicles that have decreased estradiol concentrations and of an earlier follicular stage
could be suggestive of a regulatory role in follicular growth.
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